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SUMMARY
There is much evidence for the existence of a luteolytic hormone (luteolysin)
secreted by the uterus towards the end of the oestrous cycle or pseudopregnancy in
several mammalian species. Its chemical identity is unknown. Distension of the
uterus by the insertion of a foreign body or the systemic administration of oestro¬
gen causes early regression of the corpora lutea due to the premature release of
this hormone.
Prostaglandin possesses potent luteolytic activity in all of the species
so far tested. Consequently experiments have been performed to investigate whether
the uterine luteolytic hormone could be this prostaglandin.
Distension of the guinea-pig uterus in vitro and the systemic administration of
oestrogen to guinea-pigs were found to release prostaglandin F2oC from the uterus.
The analysis of uterine venous blood samples taken from cycling sheep and guinea-
pigs showed prostaglandin F^cx to be present in levels higher at the end of the
oestrous cycle than at time3 earlier. Also the uterine venous blood of guinea-
pigs contained a high level of prostaglandin Eg at the end of the cycle.
In sheep with an ovary autotransplanted to the neck, cyclic activity ceases.
The fluid which often accumulates in the uterus of such sheep has been analysed
and was found to contain large amounts of prostaglandin Fg «•. In addition, pros¬
taglandin F-like activity was detected in the uterine venous blood but not the
carotid arterial blood of one of these sheep. The results of these findings are
discussed.
Prostaglandins Fgc*. and Eg were present in guinea-pig uterine tissue in small
amounts at the end of the oestrous cycle. Guinea-pig uteri taken on selected days
throughout the cycle were found capable of biosynthesising prostaglandins and
Eg from endogenous precursors during incubation in vitro. On any one day, 4 to 5 times
more prostaglandin F^c* than Eg was produced, with greater amounts of each being formed
nearer to the end of the oestrous cycle. Indcmethacin inhibited this synthesis of
pros taglandins.
The results obtained in this work support the hypothesis that the uterine luteo-
lytic hormone (luteolysin) is prostaglandin Fg <x. This view is discussed in rela¬
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INTRODUCTION
In 1923, Loeb observed that total hysterectomy prolonged the life span of the
corpora lutea in guinea-pigs. Oestrous cycle length was extended from the normal
17 days to beyond 60 days. Subsequently it was shown that hysterectomy performed
in the cycling 3heep, cow (Wiltbank and Casida, 1956) and pig (Spie3, Zimmerman, Self
and Casida, I960) or in the pseudopregnant rat (Bradbury, 1937), rabbit (A3dell and
Hammond, 1933) and hamster (Caldwell, Mazer and Wright, 1967) prevented the normal
regression of corpora lutea, also. However, hysterectomy performed in the dog
(Cheval, 1934), squirrel (Drips, 1919} ferret (Deanesly and Parks, 1933), opussum
(Hartman, 1925), monkey (Burford and Diddle, 1936), human (Jones and TeLinde, 1941)
and in the marsupial Trichorus vulpecula (Clark and Sharman, 1965) t^as without effect
on corpus luteum life-span. It is therefore apparent, that in several mammalian
species the uterus exerts seme control over corpus luteum function, regulating the
length of the oestrous cycle or of pseudopregnancy.
In the hani-hysterectomised guinea-pig (Fischer, 1965) and sheep (Inskeep and
Butcher, 1966} Moor and Rowson, 1966a) regression of corpora lutea occurred only in
the ovary adjacent to the retained horn. In the pig, however, hemi-hysterectcmy
resulted in only slightly extended oestrous cycles (Anderson, Butcher and Melampey,
1961). If less than one quarter of one horn remained intact though, regression of
corpora lutea occurred only in the ovary adjacent to the retained portion of horn
(du Mesnil du Buisson, 1961). In the unilaterally pregnant pig, corpora lutea in
the ovary adjacent to the non-gravid horn regressed as normal, whilst corpora lutea
in the opposite ovary were retained (Anderson, Rathmaker and Melampey, 1966). This
phenomenon was also seen in the guinea-pig (Cxenreider and Day, 1967). In the ham¬
ster (Duby, McDaniel, Spilman and Black, 1969a) and rat (Anderson, Melampey and Chen,
1966), the duration of pseudopregnancy was significantly lengthened by the removal
of one uterine horn, or one horn and the contralateral ovary. When the ovary and
the horn were removed from the same side, nozmal luteal regression occurred. All
these observations are indicative of a direct local relationship between an ovary
and its adjacent uterine horn, without the involvement of the pituitary as mediator.
Autotransplantation of the uterus in the hamster (Caldwell et al, 1967) or of
the ovary in the rat (Anderson et al, 1966a) resulted in a lengthened pseudopregnancy.
In the pig (Spies, Zimmerman, Self and Casida, I960) and guinea-pig (Loeb, 1927) uter¬
ine autotransplantation had the 3ame effect as total hysterectomy, although subsequent
workers have reported only slightly extended cycles following this procedure in both
these species (Anderson et al, 5-961; Butcher, Chu and Melampey, 1962a). In sheep,
autotransplantation of the uterus or ovary to the neck prevented corpus luteal regres¬
sion (Goding, Harrison, Heap and Linaell, 1967a? Goding, McCracken and Baird, 1967b).
However, if the ovary and uterus together were transplanted to the neck, regular oes-
trous cycles were maintained (Harrison, Heap and Linzell, 1968). These observations
indicate that the controlling influence exerted by the uterus on the ovary is disturbed
by a change in anatomical siting that involves separation of the two organs. Further¬
more, the nervous system cannot be involved 3ince autotransplantation of the two organs
together had no adverse effect. This is substantiated by the fact that uterine dener¬
vation in the pig had no effect on oestrous cycle length (Anderson and Melampey, 1962a).
It has therefore been postulated that in some mammalian species a luteolytic hormone
(luteolysin) is released from the uterus which acts on the ovaries in a local rather than
in a systemic manner. This hypothesis was one of several possible mechanisms proposed
by Loeb as far back as 1927. The apparent source of this hormone is the endometrium
for endometrial destruction in the guinea-pig had the same effect as total hysterectomy
(Butcher, Chu and Melampey, 1962b). The pathway for the hormone appears to be provided
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by the vascular system or lymph vessels. Severance of the vascular tissue between
the uterus and ovary in guinea-pigs caused maintenance of the corpora lutea, whereas
the severance and removal of part of the fallopian tube had no effect on corpora
luteal regression (Qxenreider and Day, 1967; Bland and Donovan, 1969a)• In the
rat, ligation and severing of the oviducts and the accompanying utero-ovarian vessels
in unilaterally ovariectomised-hysterectomised or intact animals extended p3eudopreg-
nancy (Butcher, Barley and Inskeep, 1969), whereas interruption of the oviduct alone
did not have this effect (Barley, Butcher and Inskeep, 1966). In the sheep, bilateral
ligation of the middle uterine arteries and veins prevented regression of the corpora
lutea (Kiraeofe, Spies and Gier, 1963; Kiracofe, Menzies, Gier and Spies, 1966).
Unilateral ligation of the same vessels ipsilateral to the ovary containing the corpus
luteum had a similar effect, whereas ligation of these vessels on the contralateral
side to the ovary containing the corpus luteum had no effect on oestrous cycle length.
In addition, bilateral or unilateral ligation of the middle uterine arteries alone did
not alter the length of the oestrous cycle. These observations are in keeping with
the local nature of the utero-ovarian relationship and indicate that the venous drain¬
age fran the uterus is involved.
Regression of the corpora lutea can be induced to occur prematurely under certain
conditions. Distension of the uterus on days 2 - 4 of the cycle by the insertion of
a foreign body into the uterine horns of the guinea-pig (Donovan and Traczyk, 1962),
sheep, (Moore and Nalbandov, 1953) and cow, (Hansel and Wagner, I960) caused shortened
oestrous cycles due to the early regression of the corpora lutea. If the foreign
body was placed in only one uterine horn, early regression of the corpora lutea in the
ipsilateral ovary occurred whereas corpora lutea in the contralateral ovary regressed
at the normal time in all three species (Bland and Donovan 1965; Ginther, Woody,
Jamekiraman and Casida, 1966). It appears therefore that the distension of the uterus
leads to the premature release of the luteolytic hormone independently from each horn.
In the pig, however, uterine distension had no effect on oestrous cycle length
(Anderson, 1962). In the aheep denervation of the distended segment of uterine horn
prevented the expected early regression of the corpus luteum (Moore and Halbandov, 1953)*
Ihe technique used though, involved severance of the blood vessels to and from that seg¬
ment of horn. Since the vasculature provides the pathway for the luteolytic hormone,
the result obtained was probably due to the severance of the blood vessels rather than
to the severance of nerves.
Certain homonal treatments can cause early regression of the corpora lutea also,
oestrogen administration during the early-or mid-part of the cycle in the guinea-pig
(Bland and Donovan, 1968a; Choudary and Greenwald, 1968), sheep (Stormshak, Kelley and
Hawk, 1968, 1969) and cow (Greenatein, Murray and Foley, 1958) caused shortened oestrous
cycles due to early regression of the corpora lutea. Similar treatment in the pseudo-
pregnant or pregnant hamster (Greenwald, 1965; Choudary and Greenwald 1969a) and in
the pregnant pig (Rigor, Self and Casida, 1963; Gardner, First and Casida, 1963) sig¬
nificantly reduced corpora luteal weight at the time of autopsy, although in the pseudo-
pregnant or pregnant rabbit oestrogen treatment had a luteotrophic effect (Hammond and
Hoboon, 1951)* Follicle stimulating hormone (F3H) administration can counteract, in
part, the luteolytic effect of oestrogen in the guinea-pig (Choudary and Greenwald,
1969b) and cow (Wiltbank, Ingalls and Rowden, 1961), whilst in the hamster FSH abol¬
ished completely the luteolytic effect of oestrogen (Choudary and Greenwald, 1969a).
In the guinea-pig, luteinizing hormone (X»H), prolactin or a combination of both did
not reverse the effect of oestrogen treatment (Choudary and Greenwald, 1969b).
Prolactin (LtH ) was also without effect in the oestrogen treated, pseudopregnant ham¬
ster (Choudary and Greenwald, 1969a). However in the cow, LH treatment following
PCd administration did reverse the effect of oestrogen completely (hiltbank et al,
1961). In the sheep, oestrogen administered on day 5 decreased the level of pituitary
LH below control values when measured on day 7 (Howland, Kirkpatrick, Woody, Pope and
Casida, 1968). These observations indicate that the pituitary may be involved in the
early regression of corpora lutea produced by oestrogen administration. However, hys¬
terectomy performed in the guinea-pig (Rowlands, 1962} HLand and Donovan, 1970) and
sheep (Stormshak et al, 1968, 1969) abolished completely the luteolytic effect of
oestrogen. In the hysterectomised cow, oestrogen administration caused only partial
corpora luteal regression (Kaltenbach, Niswender, iimmerman and Wiltbank, 1964} Brunner,
Donaldson and Hansel, 1969). Oestrogen treatment of hemi-hysterectomised guinea-pigs
resulted in early regression of the corpora lutea only in the ovary adjacent to the
retained horn. Corpora lutea in the opposite ovary were unaffected (Bland and
Donovan, 1970). It is therefore apparent that the uterus is essential as a mediator
for the luteolytic effect of oestrogen. 'The local nature of this effect is indica¬
tive of oestrogen treatment causing the premature release of the uterine luteolytic
hormone frcm each horn independently.
Progesterone treatment when begun on day 1 of the cycle resulted in shortened
oestrous cycles in the guinea-pig, sheep and cow, but not in the pig (Woody, First
and Pope, 1967). This has again been 3hown to be due to the early regression of
the corpora lutea (Ginther, 1969 } Harms and Malven, 1969} Woody, Ginther and Pope,
1968) as indicated by corpora luteal size or weight. The luteolytic effect of pro¬
gesterone was not present in the hysterectomised guinea-pig (Ginther, 1969) or sheep
(Woody et al, 1968). In the hemi-hysterectcmised, hemi-ovariectcmised guinea-pig
(Ginther, 1969,) or in the hemi-hy3terectcmised sheep (Ginther, 1968) and cow (Woody,
Ginther and Casida, 1967), progesterone treatment shortened oestrous cycle length
only when the retained uterine horn was on the same side as the ovary, containing the
corpora lutea. Therefore, it appears that the progesterone, like oestrogen, causes
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early regression of the corpora lutea due to the premature release of the uterine
luteolytic hormone.
The same story seems to be true for oxytocin. Its administration to cows
resulted in shortened oestrous cycles (Armstrong and Hansel, 1959). This was again
due to early regression of the corpora lutea and could not be prevented by the simul¬
taneous administration of LH or prolactin (Siuanons and Hansel, 1961). Donaldson,
Hansel and Van Vleck (1965) found that the oxytocin reduced the pituitary content of
gonadotropins and that in their experiments LH did in fact overcome early luteal
regression induced by oxytocin. These observations indicate that the pituitary may
be involved, although plasma levels of LH (the apparent luteotrophic hormone in cows -
see Ginther, 1968) are unaffected by oxytocin treatment (Harms, Niswender and Malven,
1969). In unilaterally, hysterectomised cows oxytocin administration shortened
oestrous cycle length only when the retained horn was on the same side as the ovary
containing the corpus luteum (Ginther, Woody, Mahajan, Janakiraman and Gasida, 196?).
Total hysterectomy abolished completely the luteolytic effect of oxytocin (Armstrong
and Hansel, 1959| Hansel and Wagner, I960). Consequently the presence of the uterus
is essential for early corpora luteal regression to occur. This indicates that the
luteolytic effect of oxytocin, like that of oestrogen and progesterone, is mediated
via the uterus. The premature release of toe uterine luteolytic hormone would account
satisfactorily for toe effect observed. However, oxytocin did not alter luteal fun¬
ction in the pig (Duncan, Bowerman, Anderson, Hearn and Melampey, 1961), guinea-pig
(Donovan, 1961), rabbit or rat (Brinkley and Nalbandov, 1963). Its effect appears
to be specific to the cow.
Overwhelming evidence has acemulated, therefore, for the existence of a uterine
luteolytic hormone (luteolysin) in some mammalian species. There have been many
attempts to isolate and identify such a hormone but with only limited success.
Bradbury, Brown and Gray (1950) reported that rat endometrial suspensions hastened
corpora luteal regression on reinfection into pseudopregnant, hysterectomised rats.
However, ether-soluble or lyophilised homogenates of rat uteri were ineffective in
shortening the length of pseudopregnancy in rats similarly hysterectomised (Kiracofe
and Spies, 1966). Likewise aqueous or ether extracts of cow endometrium collected
at different stages of the cycle were without effect in this preparation (Malven and
Hansel, 1965). However, acetone dried powder preparations of late luteal and early
oestral uteri from cows were found to be luteolytic in the majority of pseudopregnant
rabbits tested (Williams, Johnston, Lauterbach and Fagan, 1967). Also, cow endometrial
extracts obtained on days 14 and 16 of the cycle promoted luteolysis in pseudopregnant
hamsters hysterectomised on day 7 (Duby, McDaniel, Spilman and Black, 1969b). Extracts
from uteri on days 12 and 18 were ineffective. However it has been shown since that
aqueous extracts of cow endometrium from days 10 to 13 of the cycle are capable of
reducing luteal weight and progesterone content in the pseudopregnant, hysterectomised
hamster (Lukaszewaska and Hansel, 1970). The luteolytic factor present was non-
dialysable. Sephadex colimn chromatography and amnonivm sulphate precipitation
indicated the active fraction to be a protein of large molecular weight. Aqueous
extracts of hamster uteri on days 6 or 7 of pseudopregnancy were ineffective in
shortening the length of pseudopregnancy on re-injection into hysterectomised hamsters,
also (Mazer and Wright, 1968). The luteolytic factor was thermolabile and non-
dialysable. Similarly, aqueous extracts of sheep endometrium collected on days
14 or 15, but not on days 6 or 9, of the cycle were luteolytic when injected into
the hysterectomised, pseudopregnant hamster (Caldwell, Moor and Lawson, 1969a).
The luteolytic factor was again non-dialysable, but this time relatively heat stable.
Sephadex column chromatography suggested the factor to be a molecular weight below
1500 (Caldwell, Moor, Rowson and Hay, 1969b). However, injections of ether soluble,
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or lyophilised hcmogenates of sheep uteri failed to promote the regression of the
carpus luteum in hysterectomised sheep (Kiracofe et al, 1963, 1966).
Endometrial filtrates from donor pigs on days 18 - 20 of the cycle infused into
the endometrium of recipient pigs on day3 12 or 13 failed to shorten oestrous cycle
length (Anderson and Melampey, 1962b). However, luteolytic activity was detected
in pig uterine flushings collected on days 14 - 18 but not on days 1 to 10 or 20 of
the cycle (Schcmberg, 1967). The luteolytic factor was thermolabile and non-
dialysable. It appeared to be a high molecular weight protein. Similarly, an
inhibition of the synthesis of progesterone, in vitro. was obtained by introducing
into the incubation media endometrial extracts from pigs on days 16 to 18 of the
cycle (Duncan et al, 1961). The luteolytic factor was dialysable and relatively
heat stable. Extracts of the endometrium from day 12 or 13 pigs were found, surpris¬
ingly, to stimulate progesterone synthesis. Similar results have been obtained for
pig endometrial slices taken on days 8 or 14 of the cycle (Stormshak and Kelly, 1967).
Guinea-pig uterine extracts of unspecified time in the cycle were also able to inhibit
the biosynthesis of progesterone, in vitro (Cooper and Hess, 1965). However Bland
and Donovan found that aqueous, saline or acetone extracts from guinea-pig uteri did
not influence corpora luteal size when injected into hysterectomised guinea-pigs
(see Anderson, Bland and Melampey, 1969).
It is difficult to draw any conclusions about the identity of luteolysin from
these observations since the overall picture is confusing and sometimes contradictory.
However, the hormone appears to be present in the uterus towards the end of the oestrous
cycle or paeudopregnancy, as would be expected, and to be protein-like in nature. It
was found that LH caused the morphological regression of corpora lutea in rats bearing
pituitary autografts (Rothchild, 1965). It was luteolytic also in pregnant and pseudo-
pregnant hamsters when injected on day 1 through to day 5 (Choudary and Greenwald, 1969a).
Prolactin caused the morphological regression of corpora lutea also in rats when
injected 43 hours after hypophysectcmy. However, it is unlikely that these effects
are truly physiological. It is equally unlikely that the uterus can produce these
two pituitary hormones. In fact, same luteolytic extracts prepared from cow uteri
were shown not to contain any LH-like substances by their inability to induce ovula¬
tion in rabbits (Williams et al, 1967). In hysterectomised guinea-pigs, several
relaxin preparations were capable of inducing vaginal opening in half of the animals
tested (Jagiello, 1967). iresh ovulations had occurred in most of these guinea-pigs.
However relaxin had this effect in ovariectotaised guinea-pigs, also (Jagiello, 1965).
Vaginal opening was, therefore, probably due to a direct effect of relaxin. However,
the guinea-pigs uterus doss appear to be capable of producing relaxin (Hisaw, Zarrow,
Honey, falmage and Abramowitz, 1944)* In the hysterectomised cow, relaxin injections
did not cause regression of the corpus luteum (Brainier et al, 1969)* Relaxin does
not therefore appear to be luteolytic and it cannot really be considered as a candi¬
date for the uterine luteolytic hormone, neither can LH nor prolactin. Consequently
the identity of luteolysin despite all this detailed study still remains unsolved.
An interesting suggestion was put forward by Charming (see Anderson et al, 1969).
Iks proposed that the discrepancies in the results so far obtained, could be explained
by the fact that "the lytic factor may be bouni to a protein". Several of the luteo¬
lytic extracts prepared from the uterus were found to contain small amounts of carbo¬
hydrate and/or lipid material (see bukaszewaska and Hansel, 1970). These observations
may become significant since one substance of low molecular weight, prostaglandin ?2c* ,
possesses potent luteolytic activity, in vivo. Experiments have shown it to be
luteolytic in all the species so far tested, namely the rat (Fharrisa and kyngarden,
1969), rabbit (Gutknecht, Cornette and Fharrisa, 1969), guinea-pig (Hlatchley and
Donovan, 1969) sheep (KcCracken, Glew and Ocaramuzzi, 1970), monkey (Kirton, Fharrisa
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and Forbes, 1970) and hamster (Labhsetwar, 1971)♦ In vitro, however, prostaglandin
Fgc*. was found to be luteotophie (Speroff and Ramwell, 1970).
Prostaglandin Fgo< is one of the many naturally occurring prostaglandins. These
substances are 20-carbon fatty acids containing a cyclopentane ring. They differ
from one another in their degree of saturation and location of ketone and hydroxyl
groups. They have been found to be present in many tissues and to be released from
many more. Their pharmacological actions are numerous and they are usually extremely
potent (see Horton, 1969).
Prostaglandins are formed from unsaturated, straight chain, fatty acid precursors,
which in the ca3e of prostaglandin E2 and FZ<* is arachidonic acid (see Bergstran,
1966). The biosynthesis of these two compounds proceeds via a common intermediate
(Samuelsson, Granstram and Bamberg, 1967) (see Figure 1). The presence of certain
co-factors, namely hydroquinone and reduced glutathione, probably decides the pro¬
portions of prostaglandin Eg and F^oc formed by any one tissue (Nugteren, Beerthius
and van Dorp, 1967).
The precise physiological role of prostaglandins still remains obscure. Prostag¬
landins of the "E" and "F" series (Ferriera and Vane, 1967), but not the "A" series
(Horton and Jones, 1969), have been found to be efficiently removed from the circula¬
tion by one passage through the lung3. With the possible exception of those of the
"A" series, it is improbable that prostaglandins act as circulating hormones. Their
action may be local in nature, acting at the site of release or very close to it.
They may modulate the actions of other substances in the body, in part by acting on
the adenyl cyclase-cyclic AMP system (see Horton, 1969.) One or more of the prostaglan¬
dins have been found to be identical with darmstoff (Suzuki and Vogt, 1965), irin
(Anggard and Samuelsson, 1964), the menstrual stimulants (Eglinton, Raphael, Smithy











The biosynthesis of prostaglandins Fg<* and frcm arachidonic acid
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1964) and medullin (Lee, Crowshaw, Takman and Attrep, 1967). However the precise
physiological roles of these "substances" is still uncertain.
An interesting observation was that prostaglandin F^oi is present in the human
endometrium (Pickles, Hall, Best and Smith, 1965). However hysterectomy in the human
is without effect on the time interval between consecutive ovulations, therefore the
existence of a uterine luteolytic humoral mechanism in humans is extremely doubtful.
The existence of a uterine luteolytic hormone in certain other manaaalian species
is now, however, surely beyond question. Consequently the release of prostaglandins
from the uterus of the guinea-pig and sheep has been studied in order to provide evidence
for or against the hypothesis that the uterine luteolytic hormone (luteolysin) is
prostaglandin F^cx .
SECTION 1
The Identification of Prostaglandin F^c* Released by Distension of
the Guinea-pig Uterus in Vitro.
Distension of the guinea-pig uterus, in vivo, on days 2-4 of the oestrous
cycle, by the insertion of two glass beads into each uterine horn, causes premature
regression of the corpora lutea, with shortened oestrous cycles (Donovan and Traczyk,
1962). This effect has been attributed to the premature release of a uterine lute-
olytic substance (Bland and Donovan, 1966). Since prostaglandin FgC^has a luteolytic
action in guinea-pigs (ELatchley and Donovan, 1969) experiments were performed to
investigate whether distension of the guinea-pig uterus, in vitro, could release this




Incubation of Guinea-pig uterus; A female, virgin guinea-pig weighing 500 g was
smeared daily by a lavage technique. Day 1 of the cycle was taken as the day before
the post-ovulatory influx of leucocytes when cornification of the vagina was at a
maximum. On day 3 of the cycle the guinea-pig was killed by stunning and incising
the neck, the uterine horns removed and separated. One horn was distended by the
intraluminal insertion of a piece of polyethylene tubing, 3 mm wide and 30 mm long.
The other horn was similarly treated, except that the polyethylene tubing was removed
immediately following insertion. Both horns were incubated separately at 37°C in
7 ml Tyrode'3 solution for three hours and gassed with % carbon dioxide in oxygen.
Following this period, the two horns were removed and both samples of incubation fluid
were stored at -20°C prior to being assayed biologically.
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Assay Preparation; The rat fundal strip, prepared as described by Vane (1957), was
suspended in a 5 ml organ bath in Tyrode's solution at 37°G and gassed with oxygen.
Contractions of the tissue were recorded iscmetrically by a Grass force-displacement
transducer FT03C connected through a balancing circuit to a Servoscribe pen recorder.
0*2 ml aliquot portions of the incubation fluid were added to the organ bath and
assayed against a standard solution of prostaglandin E^, A dose cycle of A minutes
was employed with a drug contact time of 60 seconds.
Control responses to 5-hydrcocytryptamine, acetylcholine and histamine were obtained.
Suitable doses of the appropriate antagonists to block these responses were found.
The antagonist was added to the organ bath 30 seconds before the agonist. These doses
of antagonists were then added to the organ bath 30 seconds before 0.2 ml doses of the
incubation fluid.
Drups used in the Assay: (the concentration refers to the final concentration of the
drug in the organ bath).
a. Standard Solution: i) Prostaglandin - Suitable do3es in the range of
b. Agonistst
c. Antagonists;
Incubation with Chymotrypsin: A 0.4 ml aliquot of the incubation fluid from the dis¬
tended horn was incubated with 100of chymotrypsin at 37°C far thirty minutes.
0.2 ng/ml to 4 ng/ml, from a standard solution
containing 100 ng/ml.
ii) 5-Hydroxytryptamine creatinine sulphate - 1 ng/ml
iii) Acetylcholine chloride - 2 ng/ml
iv) Histamine acid phosphate - 1 jjlg/ml
v) Brano-lysergic acid diethylamide (BGL) - 20 and
100 ng/ml
vi) Atropine sulphate-50 ng/ml
vii) Mepyramine maleate-5 Bg/ml
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following this period, 0.2 ml of this solution was tested on the ret fundal strip for
smooth muscle contracting activity. A control dose of lOu^g chymotrypsin was tested
also for such activity.
Results
The 0.2 ml dose of Incubation fluid from the distended horn caused the rat fundal
strip to contract, whereas that from the non-distended produced no response. The
amounts of smooth muscle contracting material present were estimated to bet-
From Distended Horn * 65 ng FCE^/ml
Fiot liott-Dlstended Horn « to ng ICEjM
The contractile responses of the rat fundal strip to the 0.2 ml doses of incubation
fluid from the distended horns were neither abolished nor reduced by the addition of
the R-uromolyserpic acid diethylamide, atropine sulphate or mepyramine maleate. In
addition, the aliquot of Incubation fluid from the distended horn after incubation with
chymotrypsin still continued to contract the rat fundal strip. Chymotrypsin Itself
did not possess ary smooth muscle contracting activity In the dose used.
ff9n93.ua Ior
Distension of the guinea-pig uterus, in vitro, leads to the presence of smooth
muscle contracting activity in the incubation fluid, following: a three hour incubation
period. This activity is not due to 5-hydraxytryptaaine, acetylcholine, histamine or
any of the smooth muscle contracting peptides.
Experiment 2.
Kins female guinea-pigs weighing about 5UQ g were killed on day 3 or 4 of the
oestroua cycle, the uterine horns removed and separated. Una horn from each guinea-
pig was distended (test) as in experiment 1 (methods), the other horn from each being
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untouched (control)* Each horn was Incubated In 8 ml of Tyrode's solution under the
same conditions as in experiment 1* Following incubation and storage at -20°C, the
incubation fluid from each horn, test and control, was assayed on the rat fundal strip
for smooth muscle contracting activity*
Solvent Extraction Procedure: The individual test samples and control samples were
then pooled separately to give one "teat" and one "control" sample. These were treated
in parallel by a solvent extraction method for the isolation of prostaglandin-like
material (Bergstrc® and iamuelsson, 1963? Morton and Fain, 1967) (dee Fig. 2). Each
8ample was taken to pH 3 with hydrochloric acid and partitioned twice with an equal
volian© of ethyl acetate, The two ethyl acetate fractions were combined, reduced in
volume to 20 ml by reduced pressure evaporation and partitioned twice with 20 ml 0*1 M
pH8 phosphate buffer. The 40 ml of buffer was adjusted to pH3 with hydrochloric acid
and partitioned twice with 40 ml ethyl acetate* The ethyl acetate fraction was evapora¬
ted to dryness, under reduced pressure, the residue dissolved in 15 ml 67% ethanol and
washed twice with 15 ml petroleum spirit (bp. 60-80°C). The ethanol fraction was then
evaporated to dryness, under reduced pressure, the residue dissolved in 2 ml water*
The two final extracts (test and control) were then assayed on the rat fundal strip.
Additional Control Experiments: A uterine horn, removed from a guinea-pig on day 3
of the oestrous cycle, was incubated in the presence of a piece of polyethylene tubing,
though not distended by it* The other uterine horn from the guinea-pig was incubated
alone*(Conditions of incubation as in experiment 1 - methods). Following the three
hour period, the incubation fluid from both horns was tested on the rat fundal strip
for smooth muscle contracting, activity.
Also, two pieces of polyethylene tubing were incubated alone, in the absence of
uterine tissue. Again the incubation fluid was tested on the rat fundal strip for






















Solvent extraction procedure for the isolation of prostaglandin-
like material (i.e. polar acidic lipids)*
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Assay Preparation and Prur.3 Used: The rat fundal strip was employed under the same
conditions as in experiment 1, (methods). All samples were assayed against a standard
solution of prostaglandin E^ containing 100 ng/ml.
Results
In eight out of nine instances, the amount of smooth muscle contracting activity
in the incubation fluid from the distended horn exceeded that from the non-distended
horn (see Table 1.)
5AMPLE ACTIVITY E. ng FGEj/ml
Test (Distended horn) Control (Non-distended horn)
1 12 7.5
2 10 2.5
3 15 n.d (<3)
4 10 10
5 14 n.d (<3)
6 16 n.d (<3)
7 18 7
8 14 7
9 20 n.d U3)
n.d » no detectable activity.
Table 1: Results of the Assay of the Nine Pairs of Incubated Samples
Obtained in Experiment 2. on the Rat Fundal Strip
After the pooling of samples, followed by subsequent solvent extraction and assaying
on the rat fundal strip, the test sample (from the distended horns) contained smooth
muscle activity equivalent to 40 ng prostaglandin E^ whereas the control sample (from
the non-distended horns) contained no detectable activity (< 10 ng prostaglandin E^).
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In the additional control experiments there was no difference in prostaglandin
concentration (E5 ng prostaglandin /ml) between the incubation medium obtained
from the uterine horn incubated alone and that incubated in the presence of polyethy¬
lene tubing. Also no smooth muscle contracting activity could be detected in the
incubation media from the two pieces of polyethylene tubing.
Conclusion
Distension of the guinea-pig uterus by a piece of polyethylene tubing, followed
by a period of incubation, in vitro, leads to the presence of smooth muscle contracting
activity in the incubation medium, the active principle of vhich behaves like a pros¬
taglandin in its aolvent partitioning and pharmacological properties. The presence
of such activity cannot be attributed to an interaction between the polyethylene
tubing and uterine tissue, nor due to the leaching of the polyethylene tubing itself.
Experiment 3
Methods
Mine female guinea-pigs weighing about 500 g were killed on day 3 of the oestrous
cycle, the uterine horns were dissected out and incubated as in experiment 2, (methods).
As an additional precaution any intraluminal contents of the distended horns remaining
were washed away before incubation so that any activity detected was not due to sub¬
stances present in the lumen. Following incubation and storage at -20°0, the incuba¬
tion fluid from each horn, distended and non-distended, was assayed on the rat fundal
strip, against a standard solution of prostaglandin (100 ng/ml) for smooth muscle
contracting activity. After assaying, the individual samples from the distended and
non-distended horn3 were pooled separately to give one "test" and one "control" sample.
These two samples were then treated by the solvent extraction procedure for the isola¬
tion of prostaglandin-like material (experiment 2, methods). The final dry residue
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was dissolved in 0.5 ml 30% ethyl acetate in benzene and subjected to silicic acid
column chromatography for the separation of the various prostaglandins.
Silicic Acid Column Chromatography: This method for separating the different series
of prostaglandins was first described by Samuelsson (1963). 3 g of silicic acid
(Bio-Rad Labs, minus 325 mesh) was activated by heating at 110°C for one hour. After
being allowed to cool in a desiccator, the silicic acid was suspended in a heavy petrol¬
eum spirit (bp. 60-80°C) and the slurry poured into a glass column of internal diameter
1 cm. This gave a column of silicic acid approximately 9 cm in length. The column
was then washed with 30% ethyl acetate in benzene.
The test and control samples were applied to such colimms in a dropwise manner
with a Pasteur pipette. The flasks were rinsed with portions of the first 20 ml of
30% ethyl acetate in benzene used to elute the columns. The columns were eluted
under negative pressure, in a stepwise manner with increasing concentrations of ethyl
acetate in benzene. Concentrations of ethyl acetate used were 30%, 40$, 80% and 100$,
followed by a final elution of the column with methanol. 'Hie flow rate was approx¬
imately 1 ml per minute. Column eluate fractions were evaporated to dryness, under
reduced pressure, and the residues dissolved in 1 ml distilled water for assaying on
the rat fundal strip for smooth muscle contracting activity. Fractions 1-7 were
assayed against a standard solution of prostaglandin (100 ng/ml) whilst fractions
8-10 were assayed against a similar solution of prostaglandin F^cK.
Results
Table 2 shows the amount of smooth muscle contracting activity present in the
incubation fluid from the distended and non-distended horns following incubation
and prior to pooling. In all nine instances the activity released from the dis¬
tended horn exceeds that from the non-distended horn.
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iAi-ii'LL ACTIVITY = ng rCE.j/ml
Test (Distended horn) Control (Non-distended horn)
1 25 n.d (< 5)




6 9 n.d ( < 5)
7 7 n.d ( * 5)
8 33 3
9 9 4
n.d ® no detectable activity.
Table 2: Results of the Assay of the Mine pairs of Incubated Samples
Obtained in Experiment 3. on the Rat Fundal Strip
The results of the silicic acid column chromatography of the extracted, pooled




% Et. Ac. in
Benzene
Activity on Rat Fundal Strip
Test Control
1 20ml 30$ n.d n.d
2 4Cml 30$ n.d n.d
3 2Ctal 40$ n.d n.d
4 2Qnl 40$ n.d n.d
5 17Ctol 40% 25 ng FGE.. 25 ng PGE.
6 2Cml 40$ n.d L n.d 1
7 2Ctal 40$ n.d n.d
8 lOQnl 80$ 40 ng PGF 15 ng PGF
9 4Cml 100$ 50 ng, PGFp 7.5 ng PGFp
10 5Ctal Methanol = 15 ng PGFg E 15 ng FGFg
n.d » no detectable activity
Table 3: Results of the Assay on the Rat Fundal Strip of the Fractions
Obtained from the Silicic Acid Columns in Experiment 3
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Holmes and Horton (1968) showed that with this particular batch of silicic acid,
prostaglandins of the "E" series were eluted by 40/o ethyl acetate in benzene whilst
those of the "F" series by 80/i. Table 3 shows that prostaglandin E-like and prostag¬
landin F-like material is released from both the distended and non-distended horns.
However, whilst the amounts of prostaglandin E-like material are identical, there is
more than twice as much prostaglandin F-like material produced by the distended horns.
The amounts produced, though, are small.
Conclusion
Incubation of the distended guinea-pig uterus, in vitro, leads to the presence of
smooth muscle contracting activity in the incubation medium. After organic solvent
extraction, the polar acidic lipids isolated can be resolved into prostaglandin E-like
and prostaglandin F-like material. The incubation of non-distended uterine horns
leads in some instances to smooth muscle contracting activity in the incubation medium
also,though in smaller quantities. This activity can be resolved similarly into
prostaglandin - like material of the "E" and "F" series. However, whereas the amounts
of prostaglandin E-like material released from the distended and non-distended horns
are identical, the distended horns produced more than twice as much prostaglandin F-like
material. The amounts released were too small to permit further identification.
Experiment L
This experiment was designed to assess quantitatively the release of the "active
material" from the distended and non-distended uterine horns with time.
Methods
Four guinea-pigs were killed on day 3 of the oestrous cycle, the uterine horns
dissected out and separated. One horn from each animal was distended as in experiment
1 (methods) and all eight horns were incubated separately in 10 ml of Tyrode's solution,
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aerated with oxygen, at 37°C. 0.2 ml aliquot portions were taken every two hours and
assayed on the rat fundal strip for smooth muscle contracting activity against a standard
solution of prostaglandin Y^oc (100 ng/ml).
Results
The assay results for the amount of "activity" released fey the four individual
distended horns have been pooled, as have those for the non-distended horn3 and are
represented in Figure 3.
The initial release of the "active material" frcm the distended horns is small,
though there is a large release between two and four hours of incubation. Smaller
increases occur between four and six hours respectively. No "active material" is
released from the non-distended horns until after four hours of incubation. However,
there is quite a large rise after six hours.
Conclusion
There is an increase in the total amount of active material released with time.
The total amount released frcm the distended horns at any one time is greater than
the amount released from the non-distended horns. The actual mechanism by which
polyethylene tube insertion promotes the release of "active material" frcm the uterus
was not studied and is, so far, unknown. It may be noted that the mechanism by which
uterine bead insertion, in vivo, causes the premature release of a luteolytie substance
frcm the uterus is also unknown. In this experiment as in the other experiments in
this series, care was taken not to damage the uterus whilst inserting the tubing thus
minimising tissue damage as a contributory cause to the effect produced. However,
the large rise in "active material" released frcm the non-distended horns after six














Total biological activity released by distended and non-distended uterine
horns during an eight hour incubation. Aliquot portions were taken every
two hours and assayed on the rat fundal strip (experiment £).
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Experiment 5
In this experiment an attempt was made to identify more conclusively the "active
material" released by distension of the uterus.
Methods
Thirty-five guinea-pigs were killed on day 3 of the oestrous cycle, the uterine
horns dissected out and separated. One horn from each animal was distended as in
experiment 1 (methods), the other horn was left untouched and acted as the control.
Each horn was incubated in 10 ml Tyrode's solution, gassed with oxygen at 37°C for
5 hour3. The fluid obtained from the incubated samples was pooled so as to give one
"test" sample (from the distended horns) and one "control" sample (frcsn the non-distended
horns). Both samples were extracted by the solvent extraction procedure 83 in experi¬
ment 2 (methods), followed by silicic acid column chromatography.
Silicic Acid Column Chromatography; Columns were prepared and run in a similar manner
as in experiment 3 (methods). However a different batch of silicic acid was used
(Sigma SIL-R, low grade 100 mesh). Experience has shewn that variations in "retention"
properties occur among different batches of silicic acid. Consequently a control column
using authentic prostaglandins was first prepared and run as follows.
A. 5 g of the silicic acid was activated by heating in an oven at 110°C for one
hour. After being allowed to cool, the silicic acid was suspended in heavy petroleum
spirit (b.p. 60-80°C) and poured into a glass column of 1 cm diameter to give a column
of silicic acid about 9 cm in length. The column was then washed with 30$ ethyl
acetate in benzene. 2.5ju.g each of prostaglandin and prostaglandin F^oC dissolved
in 0.5 ml 30$ ethyl acetate in benzene, were then applied to the column in a dropwise
manner using a Pasteur pipette. The flask was rinsed with aliquot portions of the
first fraction of eluant. The column was eluted under negative pressure with increa¬
sing concentrations of ethyl acetate in benzene as shown in Table U* Each fraction
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was 40 ml in volume. dilution of the column was completed by a % ml fraction of
methanol (fraction 17).


















Table 4: Percentages of Ethyl Acetate in Benzene used to Elute Authentic
Prostaglandins from a Silicic Acid column in Experiment 5
f
The fractions obtained from the column were evaporated to dryness, under reduced
pressure and assayed on the rat fundal strip. Fractions 1-10 were assayed
against a standard solution of prostaglandin (100 ng/ml) whilst fractions U - 17
were assayed against a similar solution of prostaglandin F^tx •
After the results of running this column were obtained, the solvent extracted
"test" and "control" samples were applied to similar columns and eluted under negative
pressure with the volumes and concentrations of ethyl acetate in benzene a3 shown in
Table 5.
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Fraction Volume of % Ethyl Acetate in









Table 5; Volumes of £luant and Percentages of Ethyl Acetate in Benzene
used in the Silicic Acid Column Chromatography of the "Test" "
and "Control" Samples in Experiment 5
The fractions obtained from the columns were evaporated to dryness, under reduced
pressure, the residue dissolved in 1 ml of water and assayed on the rat fundal strip
for smooth muscle contracting activity. Fractions 1-5 were assayed against a
standard solution of prostaglandin (100 ng/ml), whilst fractions 6-8 were
assayed against a similar solution of prostaglandin a.
Parallel Bio-Assay: Following the assay on the rat fundal strip, fraction 6 from
both columns was assayed on three further biological preparations against standard
solutions of prostaglandin and prostaglandin F^c>c (100 ng/per ml or Iji g per/ml
depending upon the sensitivities of the tissues to each prostaglandin)!. The assay
preparations used were:-
1) Rabbit .ie.junum - A piece of rabbit jejunum about one inch long was suspended
in a 5 ml organ bath in Tyrode's solution, bubbled with air, at 37°C* Contractions
of the tissue were recorded isometrically using a Grass force displacement transducer
FT03C, connected through a balancing circuit to a Servoscribe pen recorder* A dose
- 23
cycle of 4 minutes was employed with a drug contact time of 60 seconds.
ii) Jini colon - A piece of ascending colon, about l|H long, from the Mongolian
jird (Meriones unguiculatus) was suspended in a 2 ml organ bath in the de JaIon's colon
Ringer solution, bubbled with oxygen,at 30°C. Contractions of the tissue were recorded
isotonically by means of a frontal writing lever on a smoked drum. A dose cycle of
four minutes was used with a drug contact time of 60 seconds.
iii) Cuinea-rif,' ileum - A piece of guinea-pig ileum, about one inch in length,
was suspended in a 5 ml organ bath in Tyrode's solution, bubbled with air, at 37°C.
Contraction® of the tissue were recorded isotonically by means of a frontal writing
lever on a smoked drum. A dose cycle of four minutes was used with a drug contact
time of 60 seconds.
Oas Chromatorraphv/Mass Spectrometry* Following the parallel bioassay, fraction 6
from the "test" column only was subjected to analysis by combined gas chromatography/
mass spectrometry (Thompson, Los and Morton, 1970), For this procedure, derivative
formation is necessary.
This fraction was evaporated to dryness in a desiccator, in vacuo, the residue dis¬
solved in 0.2 ml of methanol and transferred into a 0.5 ml stoppered tube. The flask
was rimed with a further 0.2 ml of methanol and the washings added to the stoppered
tube. The methanol was then evaporated off by a fine jet of air. The residue remain¬
ing was methylated by a reaction for 30 minutes with a freshly prepared solution of
diazemethane in diethyl ether-methanol (9x1). Following this reaction period, the
excess solution was vaporised again by the use of a fine jet of air. The trimethyl-
silyl ether was then formed by the addition of 25 fxl bis-(trlmethylsilyl)-trifluoro-
acetamide (B3TFA) to the methyl ester, a reaction taking three hours to go to completion.
The methyl ester/trim©thyIsilyl ether (Me/TMS) of authentic prostaglandin F^c* (500 ng)
was prepared also in a similar manner. 10 jil quantities of each sample were injected
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on to the gas chromatographic column without removal of the B3TFA.
Analysis was performed on an LKB 9000 gas chromatograph-mass spectrometer. The
column (1,5 m x 1,5 mm i.d.) was packed with 3% OV 1 on Oupasorb AW, 100-120 mesh,
pre-treated with dimethylchlorosilane in carbon tetrachloride. The column temperature
was 200°C, The carrier gas was helium which flowed at 20 ml per minute. The mass
spectra were recorded at an electron voltage of 27# 5»
A 10 jjH sample of the Ke/TMS derivative of authentic prostaglandin Fg<* was injected on
to the column. Its retention time, taken from the gas chromatographic recording,
was noted. A mass spectrum was taken at this time. The same derivative of fraction
6 from the "test" sample was then injected on to the column. A mass spectrum of the
effluent from the column was taken at the previously noted retention time for the Me/TMS
derivative of authentic prostaglandin
Further Purification of "Test" Sample: The remnants (15yUl) of the "reacted" fraction
6 from the "test" column were evaporated to dryness in a desiccator in vacuo.and re-
extracted. The residue was dissolved in 20 *1 of 67# ethanol and washed twice with
20 ml portions of petroleum spirit (b.p, 60°C - 80°C). The ethanol fraction was evap¬
orated to dryness under reduced pressure, the residue dissolved in 0.5 ml 30# ethyl
acetate in benzene and subjected to silicic acid column chromatography, as described
previously in this experiment. The fractions obtained from the columns were evapora¬
ted to dryness under reduced pressure, the residues dissolved in 1 ml of water and
assayed on the rat fundal strip for smooth muscle contracting activity. Fractions
1-5 were assayed against a standard solution of prostaglandin (100 ng/ml), while
fractions 6-8 were assayed against a similar solution of prostaglandin F^c* . Fraction
6 from the column was then subjected to analysis be combined gas chromatography and mass
spectrometry as described previously.
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Results
i) Result of the Silicic Acid Column Chromatography Using
Authentic Prostaglandins
The result is shown in Figure 4. Prostaglandin E^ was totally eluted from the column
by 60% ethyl acetate in benzene (fractions 6 - 10). The second fraction of 70$> ethyl
acetate in benzene began to elute the prostaglandin F^cx (fraction 11) but the majority
was eluted by the two initial fractions of BC% ethyl acetate in benzene (fractions 12
and 13)* Elution of the column was completed by fraction 15*
ii) Results of the Silicic Acid Column Chromatography of the
"Test" and "Control" Samples
The results are shown in Figure 5» Based on the results of the column using authentic
prostaglandins, fraction 4 (110 ml of 60% ethyl acetate in benzene) elutes prostaglandins
of the "£" series from the column, vMlst fraction 6 (150 ml of 8C$ ethyl acetate in
benzene) elutes prostaglandins of the "F" series. As can be seen, the amount of
prostaglandin E-like material in the "test" and "control" samples is small and nearly
identical. There is activity equivalent to 30 ng prostaglandin E^ in the "test"
sample and activity equivalent to 25 ng prostaglandin in the "control".
However, there is a large difference in prostaglandin F-like activity. There is
activity equivalent to 1 jig of prostaglandin Fgpc in the test sample but activity equi¬
valent to only 100 ng in the control, a ten-fold difference. There was a small amount
of activity also in the methanol fraction from both columns.
iii) Results of the Parallel Bio-Assay
Table 6 shows the results of the bio-assays of fraction 6 from the "test" and "control"
columns on the rat fundal strip, rabbit jejunum, ascending colon of the mongolian jird
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Table 6: Results of the Parallel Bio-Assay of Fraction 6 Obtained from
the Silicic Acid Columns in Experiment 5. Assayed against
Prostaglandin E.. (PGR.) and Prostaglandin Fr<*-(FGF,^*.) on~Four
Preparations,
The estimated amount of activity in fraction 6 from the "test" column was similar
on all four tissues when assayed in terms of prostaglandin (greatest index of
discrimination =2), However, the estimates differed widely when the sample was
assayed in terms of prostaglandin E^ (greatest index of discriminations297). In
addition, qualitative differences in contractions of the rabbit jejunum and guinea-
pig ileum elicited by prostaglandins and F^ocwere observed. The response to E^
tended to be quick in onset but shorter in duration. The response to prostaglandin
F^oCon the other hand was slower in onset but of longer duration. The responses
produced by fraction 6 from the "test" column resembled those produced by prostaglandin
f2** "
Fraction 6 from the "control" column produced a similar set of results. The
amount of activity present, however, was 10-12 times less than that in fraction 6
from the "test" column.
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iv) Results of the Cas Chroma topraphv/Fiass Spectrometry
The methyl ester/trimethyl ether (Me/TMS) of authentic prostaglandin F^oC on gas
chromatography had a retention time of 16.0 minutes. A mass spectrum was taken at
this time. The Me/TK3 derivative of fraction 6 from the "test" column contained
many substances as was shown by the gas chromatographic recording. The trace of the
mass 3pectrum taken of the effluent from the column at 16,0 minutes had many ra/e
peaks. However, those peaks characteristic of the Me/TM3 derivative of authentic
prostaglandin F^ocat m/e values of 494# 513, 569 and 584 were absent,
v) Results following further purification of the "te3t" sample
After purifying the "test" sample further the results of the silicic acid column
chromatography indicated that there was still prostaglandin F-like activity, equiva¬























< 25 ng FGE,
<25 ng FGEt
< 25 ng PGEA
< 25 ng FGE x
<25 ng FGE x
100 ng FGF„ .
c 50 ng FGFf
50 ng FGF^
Table 7: Results of the Assay on the Rat Fundal Strip of the
Fractions Obtained from the Silicic Acid Column
following Further Purification of the "Test" Sample in
Experiment 5.
The Me/TIB derivative of authentic prostaglandin F^t* on gas chromatography had a
retention time of 16.1 minutes. The trace of the mass spectrum taken at this time
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contained the m/e peaks typical of prostaglandin Figure 6 shows the ten peaks
of m/e above 300 on which positive identification was made. These peaks occur at
m/e values of 307, 333, 353, 379, 404, 423, 494, 513, 569 and 564. Peaks below m/e
300 tend to be lost in the background "noise" and are therefore of little value in
affording identification. The Me/TKS derivative of the material in fraction 6 from
the silicic acid column on gas chromatographic analysis produced a peak at 16.1 minutes.
The trace of the mass spectrum taken on the effluent from the column at this time con¬
tained the ten peaks of m/e above 300 characteristic of prostaglandin Fg<x • Phis evi¬
dence indicates that prostaglandin F^cx is present in the "test" sample. Other prom¬
inent peaks occurring in the mass spectrum at m/e 323, 339, 361, 380, 437 and 451 are
due to the presence of interfering substances.
Conclusion
Distension of the guinea-pig uteru3 by the intraluminal insertion of a piece of
polyethylene tubing leads to the release of prostaglandin F-like material. The amount
released is ten times greater than that released from non-distended horns. The amount
of prostaglandin E-like material released from the distended uterine horns is much
smaller and is nearly identical to that released from non-distended horns. The parallel
bio-assays confirmed that the material present in fraction 6 from each silicic acid
column closely resembled prostaglandin Fbut could not be prostaglandin E^, as reflec¬
ted in the indices of discrimination of 2 and 297 respectively.
At the first attempt, combined gas chromatography and mass spectrometry failed to
confirm that the material in fraction 6 from the 'test1 column was prostaglandin Fg«x •
This was due to the presence of large amounts of contaminating substances which
probably interfered with the chemical reactions involved in derivative formation.
After further purification, however, analysis by gas chromatography and mass spec-
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Fig. 6
Line diagrams of mass spectra (m/e peaks greater than 300) of the Me/TMS
derivative of material released from distended uterine horns and of
authentic prostaglandin (experiment 5). Ordinate: percentage relative
intensity of peaks. Abscissa: m/e value of peaks.
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trometry confirmed the presence of prostaglandin F^cx in the 'test' sample (from
the distended horns). The amounts of prostaglandin E-like material released were
too small for further identification.
Experiment 6
In the previous experiment combined gas chromatography and mass spectrometry
failed in the first instance to confirm the presence of prostaglandin F^cx. in the
'test' sample and in the second instance no 'control' sample was included. This
experiment was therefore repeated.
Methods
Thirty guinea-pigs on day 3 of the oestrous cycle were killed, their uterine
horns removed and separated. One horn from each animal was distended by the intra¬
luminal insertion of a piece of polyethylene tubing, the other horn was left untouched
and acted as the control. All horns were incubated separately in 10 ml Tyrode's
solution, aerated with oxygen, at 37°0 for 5 hours. Following this period, the
incubation fluid from the distended horns was pooled to give one "test" sample.
Likewise the incubation fluid from the non-distended horns was pooled to give one
"control" sample. Both pooled samples were then subjected to the solvent extraction
procedure as in experiment 2 (methods). The final fractions from the column were
evaporated to dryness under reduced pressure, the residues dissolved in 1 ml water
and assayed on the rat fundal strip for smooth muscle contracting activity. Fractions
1-5 were assayed against a standard solution of prostaglandin (100 ng/ml) whilst
fractions 6-8 were assayed against a similar solution of prostaglandin F^cx.
Gas Chromatography/Mass Spectrometry: Fractions 6 from the "test" and "control"
columns were subjected to analysis by combined gas chromatography and mass spectrom¬
etry as in experiment 5 (methods), except that two derivatives of each fraction were
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prepared. The fractions were taken to dryness in a desiccator, in vacuo, the
residues dissolved each in 0,4 ml methanol and divided into two equal portions.
One portion of each was used to form the Me/TMS derivative as described previously
(experiment 5, methods). The other half was used to form the methyl ester/tri-
fluoroacetate (Me/TFA). The methyl ester was prepared first. The trifluoroacetate
was prepared by reacting the methyl esters for 2 hours with 200^1 of trifluoroacetic
anhydride which was then removed in a desiccator, in vacuo. The residues remaining
were dissolved in 25 f/1 of hexane.
The Me/TMS and Me/TFA derivatives of authentic prostaglandin Fgoc(500 ng) were
prepared also, 10jul samples of all derivatives were injected on to the gas chroma¬
tography colmn. The column temperature was 190°G for the Me/TFA compounds and 200°C
for the Me/TMS derivatives. Other column conditions were the same as in experiment 5
(methods). Mass spectra, taken at the appropriate retention times, were recorded at
an electron voltage of 27.5.
Results and Conclusion
i) Result of the Silicic Acid Column Chromatography
The result is represented in Figure 7 and is similar to that obtained in experiment 5.
The amount of prostaglandin E-like activity released from the distended and non-
distended horns is small and nearly identical (= SO ng prostaglandin E^), whereas
there is a large difference in the amount of prostaglandin F-like activity. There
is activity equivalent to 700 ng prostaglandin Fgoc. in the "test" sample (from the
distended horns) but activity equivalent to only 80 ng prostaglandin F^ot in the
"control" (from the nonrdlatended horns), again a notable difference,
ii) Results of the Gas Chromatopraphy/Mass Spectrometry
The Me/TMS and Me/TFA derivatives of authentic prostaglandin Fgocon ga3 chromatography
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Results of the bioassay on the rat fundal strip of the silicic acid column
chromatography of the "test" sample (from distended uterine horns) and
"control" sample (from non-distended uterine horns) (experiment 6).
- - -"control" sample
(non-distended horns)
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same derivatives of fraction 6 from the "test" column produced similar peaks at identi¬
cal retention times in amounts agreeing with the bioassay result. The same deriva¬
tives of fraction 6 from the "control" column, however, did not produce any peaks at
these retention times, since the amounts present were subthreshold for detection. Mass
spectra were taken at the appropriate retention times irrespective of whether there was
a ga3 chromatographic peak or not* Line diagrams of these spectra showing peaks of m/e
above 300 are shown in Figure 8.
On inspection of the Me/TMS derivatives fir3t, in fraction 6 from the "control"
column there are 4 prominent peaks at m/e 361, 382, 437 and 451. These peaks are
present also in fraction 6 from the "test" column but, in addition, there are ten
other peaks atm/e 307, 333, 353, 379, 404, 423, 494, 513, 569 and 584. These are the
peaks characteristic of the Me/TJS derivative of authentic prostaglandin f^c*. A
similar pattern is seen in the Me/TFA compounds. There is one common peak in both
fractions at m/e 326. Fraction 6 from the "test" column has three additional promin¬
ent peaks at m/e 314, 428 and 542* These are the three peaks characteristic of the
Me/TFA derivative of prostaglandin F^c*. •
On this evidence of gas chromatography and mass spectrometry performed on two
derivatives, it can be concluded that the "te3t" sample (from the distended horns)
contains prostaglandin F^oc , whilst no detectable amounts are present in the
"control" sample (from the non-distended horns). The common peaks occurring in the
mass spectra of both derivatives are due to the same impurities present in approximately
equal amounts in each sample. In addition, on gas chromatographic evidence, no
prostaglandin F^<x (retention times; Me/TMS derivative 21 minutes, Me/TFA derivative
7 minutes) nor 5(X, 7<*, - dihydroxy-ll-oxo-tetranorprostanoic acid (the main urinaiy
metabolite of prostaglandin F^cx in the guinea-pig; retention times, Me/TMS derivative
7 minutes, Me/TFA derivative 4.25 minutes) could be detected in either sample, since
no gas chrcmotographic peaks occurred at these retention times.
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Line diagrams of mass spectra (m/e peaks greater than 300) of the Me/TMS and
Me/TFA derivatives of "control" sample (from non-distended uterine horns),
"test" sample (from distended uterine horns) and authentic prostaglandin F„
Principal peaks characteristic of are indicated by horizontal numbering,
other major peaks by vertical numbering (experiment 6). Ordinate: percentage
relative intensity of peaks. Abscissa: /e value of peaks.
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General Conclusion
In this series of experiments, an attempt has been made to assimilate in vitro.
conditions which, in vivo, are known to prcmote the release of a uterine luteolytic
substance. The cumulative evidence of solvent partition behaviour, column chroma¬
tography and pharmacological properties, the parallel bioassay results, and,in particu¬
lar, the combined gas chromatography and mass spectrometry results has shown that
distension of the guinea-pig uterus in vitro on days 3 or 4 of the oestrous cycle
leads to the release of prostaglandin F^oc . This substance is known to be luteo¬
lytic in guinea-pigs (HLatchley and Donovan, 1969). Hie result obtained here may
account far the oestrous cycle shortening effect in guinea-pigs caused by distension
of the uterus on days 2 to 4, which has been attributed to the premature release of a
uterine luteolytic substance (Bland and Donovan 1966).
The mechanism by which distension of the uterus, in vitro, causes the release of
prostaglandin F^oC has not been studied here or elsewhere. Section 5 indicates that
it is not due to a simple breakdown of tissue with the release of 3tored prostaglandin.
However, it may be due to a local breakdown of the endometrial tissue in contact with
the polyethylene tubing with the release of both prostaglandin precursors and synthe-
sising enzymes resulting in the production of prostaglandin,ot.
The contraceptive effect of intra-uterine devices in women has been attributed
to an interaction between the device and the endometrium with resultant low grade
inflammation and hyperaemia (Davies and Lesinski, 1970). HLatchley and Donovan
(personal communication) have observed that the guinea-pig uterus into which beads
have been placed has an enriched blood supply. This may indicate low grade inflam¬
mation with the resultant breakdown of cells and possibly synthesis and release of
prostaglandin Fg , Prostaglandins are released during inflammatory conditions
(Willis, 1969). This "cell breakdown theory" does not quite correlate with the
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observations of Bland and Donovan (1968b). They found that the bead insertion on
days 2, 4 and 8 only caused premature luteolysis, whilst bead insertion on days 5,
6, 7, 9 and 10 had no significant effect on the size of the corpora lutea at autopsy
on day 12. (Bead insertion on day 3 was not studied, although Donovan and Traczyk
(1962) have shown this to cause premature luteolysis also). However, close examina¬
tion of the results on day 8 shows that the standard error of corpora lutea size in
the control group on that day is small compared with the same standard errors in all
other groups. A similar standard error would probably have made the result not sig¬
nificant. Therefore the significant result obtained on day 8 may be an artifact of
statistical analysis. Blatchley and Donovan (1970) showed that bead insertion on
days 5 to 8, the period of implantation, resulted in the production of large deci-
ducmata. They speculate that the induction of deciduomata blocks the regression of
the corpora lutea caused by the presence of foreign bodies in the uterus. The mech¬
anism by which this is achieved was not discussed. It cannot be due to a release of
the luteotrophic agent necessary for the maintenance of the corpora lutea during the
early stages of pregnancy, which is antagonistic to the luteolytic agent, since this
is produced by the placenta (Bland and Donovan, 1969b). However, Bland and Donovan
(1968b) in their experiments reported that the premature luteal regression was not
evident even in those animals treated on days 5 to 7 in which decidual tissue was
absent. If their significant result obtained on day 8 is, in fact, an artifact,it
may be that the distension of the guinea-pig uterus, by bead insertion, on days 2 to
4 ori^y, causes premature regression of the corpora lutea, whilst distension after
this in the cycle has no significant effect on the corpora luteal size at autopsy
on day 12. This would correlate well with the "cell breakdown theory" as to the
mechanism of action, especially as the endometrium, the surface in contact with the
polyethylene tubing, is the apparent site of the uterine luteolytic hormone (Butcher,
Chu and Melampey, 1962a, b).
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SECTION 2
The Release of Prostaglandin FqcA. from the Uteru3 of
Guinea-pips following Oestrogen Treatment
The treatment of guinea-pigs with oestrogen in the early- or mid-part of the
oestrous cycle causes premature regression of the corpora lutea (Bland and Donovan,
1968aj Choudary and Greenwald, 1969). In the hysterectomised guinea-pig, oestrogen
treatment has no such effect (Rowlands, 1962), whereas in the hemi-hysterectomised
guinea-pig, oestrogen treatment causes regression of the corpora lutea only in the
ovary adjacent to the retained horn (Bland and Donovan, 1970). These findings indi¬
cate that the luteolytic effect of oestrogen is mediated via the uterus, its local
nature being compatible with the involvement of the uterine luteolytic hormone (luteo-
lysin). It Is possible that the premature release of this hormone from the uterus
may account for the luteolytic effect of oestrogen treatment. Therefore, since the
uterine luteolytic hormone may be prostaglandin c*C (see section 1), the prostaglan¬
din level in the uterine venous blood of guinea-pigs following oestrogen treat¬
ment has been estimated.
Methods
Treatment of Guinea-pigs and Collection of Uterine Venous Blood Samples
(performed by F« R. Blatchley and B.T. Donovan).
Guinea-pigs were Injected subcutaneously with 10 jig oestradiol benzoate/day
from day 4 to day 6 of the cycle (day 1 * day of oestrus). On day 7 each was
anaesthetised with pentobarbitone sodium and injected with 50G0IU heparin, intra¬
venously. The utero-ovarian vein on one side was exposed and blood collected from
it into a cooled tube by means of a needle and silastic catheter for approximately
1-1^ hr. Centrifugation of the blood at 4°C was carried out as soon after collec¬
tion as possible and the plasma stored at -20°C until extracted. In addition, five
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guinea-pigs were hysterectomised on day 4, treated with 10 fjig oestradiol benzoate/day
from days 4-6, and blood collected from the intact utero-ovarian vein on day 7. Blood
fran untreated guinea-pigs was similarly collected on day 7 for control purposes.
Extraction of Plasma Samples
Plasma from 4-5 treated guinea-pigs was pooled in each experiment so as to give
a volume of approximately 30 ml. Plasma samples from untreated guinea-pigs were
pooled similarly. Each pooled sample was extracted by the solvent partition proced¬
ure as in section 1, experiment 2 (methods). The dry residue obtained was dissolved
in 0.5 ml 30$ ethyl acetate in benzene and subjected to silicic acid column chroma¬
tography as in section 1, experiment 5 (methods). Each fraction obtained from the
columns was evaporated to dryness, the residue dissolved in 1 ml water and assayed on
the rat fundal strip in the manner described in section 1, experiment 1 (methods).
Fractions 1-5 were assayed against a standard solution of prostaglandin E^ (100 ng/ml),
fractions 6-8 against a similar solution of prostaglandin Fg<< .
Mass Spectrcmetry/Gas Chromatography - Where analysis by combined gas
chromatography and mass spectrometry was performed, fraction 6 from the silicic acid
column, following bioassay, was evaporated to dryness, the residue dissolved in methanol
and transferred to a 0.5 ml stoppered tube. The methyl ester/trimethylsilyl ether
(Me/TMS) was prepared, as in section 1, experiment 5 (methods). The Me/TMS derivative
of authentic prostaglandin Fg<x. (500 ng) and of 5 c*, 7ot -dihydroxy-ll-oxo-
tetranorprostanoic acid were prepared in a similar manner also. Ten microlitre
quantities of these two standards were injected separately on to the gas chromato¬
graphic column. Their retention times were noted and mass spectra taken. A lO^cl
quantity of the toe/TMS derivative of each fraction 6 was injected on to the gas chroma¬
tographic column also. Mass spectra were taken of the effluent from the column at the
previously noted retention times for the two standard compounds.
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Recovery Experiments - Experiments were performed to estimate the
percentage recovery of prostaglandin Fgec from the guinea-pig blood over a range of
concentrations. Three guinea-pigs were stunned by a blow on the head, their necks
incised and blood allowed to drain from the wound into a heparinised vessel. The
amounts obtained varied between 10 and 20 ml. Sufficient prostaglandin F^oc was
added to give concentrations of 10, 30 and 330 ng/ml. The blood was maintained at
37°C for one hour after which each sample was centrifuged and the red cells discarded.
Each plasma sample was then solvent extracted and subjected to silicic acid column
chromatography, as previously described. The fractions obtained from the columns
were evaporated to dryness, the residues dissolved in 1,0 ml water and assayed on
the rat fundal strip. Fractions 1-5 were assayed against prostaglandin E^, fractions
6-8 against prostaglandin F2°t*
Results
Prostaglandins of the "F" series are eluted from silicic acid columns by 80$
ethyl acetate in benzene (fraction 6) (see section 1, experiment 5, results). In
the recovery experiments, prostaglandin F^&cwas eluted from columns by this fraction
in every case. The average percentage recovery was 45.5$ (range 40-50$) and was
independent of the initial concentration of prostaglandin F^oc in the blood over the
range tested.
The level of prostaglandin F^ot in the utero-ovarian blood of treated, non-
treated and treated, hysterectomised guinea-pigs is shown in Table 8* These levels
are based on the bioassay result of fraction 6 from the silicic acid columns and are
corrected for a recovery of 45.5$.
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6* 9-11 < 2.2
7 4.2—6.2 <1.9
8*f 11-13 <1.9
* Gas chromatography and Mass Spectrometry performed in
these experiments.
■f- Hysterectomised oestrogen-treated <1.8 ng FGFgot/ml
Table 8: Level of Prostaglandin F^<*-(ng/ml) in Blood taken from the
Utero-Ovarian Vein on Day 7 of the Oestrous Cycle of Oestrogen
Treated and Control Guinea-pigs
In six out of eight experiments there was a greater amount of prostaglandin
Fgoc in the utero-ovarian blood of intact guinea-pigs pretreated with oestrogen
than in non-treated control animals. The levels ranged from 4 to 29 ng/ml. No
prostaglandin F,>o< could be detected in the control groups, nor in the oestrogen
treated, hysterectomised group (<1.8 ng/ml).
Results of Gas Chroma tocraphy/Mass Spectrometry
Analysis by combined gas chromatography and mass spectrometry was performed in
two of the eight experiments. The Me/'TKS derivative of authentic prostaglandin Fgt*.
had a retention time on gas chromatography of 19*3 minutes. Mass spectra taken at
this retention time of the effluent from the gas chromatographic column of the Me/'fMS
derivative of the various samples analysed in one experiment are summarised in the
line diagrams in Figure 9. As noted previously, the characteristic m/e peaks of
values above 300 of the Me/TM3 derivative of authentic prostaglandin Fgo< occur at
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Line diagrams of mass spectra (m/e peaks greater than 300) of the Me/TMS
derivative of material extracted from the utero-ovarian venous blood of
intact guinea-pigs treated with oestrogen, hysterectomised guinea-pigs
treated with oestrogen, and intact, non-treated control animals, and of
authentic prostaglandin F^c* . Retention time on gas chromatography
19.3 minutes. Frincipal peaks characteristic of F-c*are indicated by
horizontal numbering, other major peaks by vertical numbering,. Ordinate:
percentage relative intensity of peaks. Abscissa: m/e value of peaks.
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307, 333, 353, 379, 404, 423, 494, 513, 569 and 584. These peaks are present In
the mass spectrum of the Me/TM3 derivative of the extracted utero-ovarian venous
blood taken from the guinea-pigs treated with oestrogen, but not in the mass spectra
of the same derivative of similar blood taken from oestrogen treated, hysterectomised
animals, nor non-treated, intact animals. Other peaks occurring in the spectra are
due to common impurities,
A duplicate result was obtained in the other experiment where gas chromatography
and mass spectrometry was performed. This evidence shows conclusively that prostag¬
landin Fgt* is present in the utero-ovarian blood of guinea-pigs pre-treated with
oestrogen but cannot be detected in similar blood of pre-treated, hysterectomised
guinea-pigs, nor in non-treated intact guinea pigs.
The main urinary metabolite of prostaglandin (5 c*- , 7 oC - dihydroxy-lL-oxo-
tetranorproetanoic acid) is eluted from the silicic acid columns by 80% ethyl acetate
in benzene (fraction 6) (Los, M,, unpublished observations). The Me/TKS derivative
of this metabolite on gas chromatography had a retention time of 5.3 minutes. Its
mass spectrum had characteristic peaks of m/e values above 200 at 217, 241, 254, 278,
281, 353, 368, 427 and 443. The molecular ion (m/e 458) was not seen.
Mass spectra taken at the retention time of 5.3 minutes of the effluent from the
gas chromatographic column of the Ke/TMS derivative of fraction 6 from the silicic
acid columns of the extracted utero-ovarian venous blood taken from treated and non-
treated, intact guinea-pigs did not contain any of these peaks, except the one at
m/e 217 (Figure 10). On this evidence it can be concluded that the main guinea-pig
metabolite of prostaglandin Fgc* was not present in amounts that could be detected in
the utero-ovarian venous blood of these guinea-pigs. (Utero-ovarian venous blood
taken from the oestrogen treated, hysterectomised group of guinea-pigs was not analysed
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Line diagrams (m/e peaks greater than 200) of the Me/TM3 derivative of
material extracted frcm the utero-ovarian venous blood of oestrogen
treated and non-treated (control) guinea-pigs, and of authentic ,
7cx -dihydrcocy-ll-axo-tetranorprostanoic acid. Retention time on ga3
chromatography, 5.3 minutes. Peaks characteristic of the authentic
compound are indicated by horizontal numbering. Ordinate: percentage
relative intensity of peaks. Abscissa: m/e value of peak.
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In addition, on the basis of ga3 chromatographic evidence, prostaglandin
could not be detected in those samples analysed. Furthermore, on the basis of
the bioassay results only, no prostaglandins of the '1' series were detected in any
of the blood samples analysed ( <0.5 ng prostaglandin E^/ml - this value is uncor¬
rected for recovery.)
Conclusion
The treatment of guinea-pigs with oestrogen during the early- or mid-part of
the oestrous cycle causes early regression of the corpora lutea due probably to the
premature release of a uterine luteolytic substance (SLand and Donovan, 1970). The
experiments perfcanned in this section have shown prostaglandin F^ck. to be present in
the utero-ovarian venou3 blood of guinea-pigs receiving oestrogen treatment Whereas
no prostaglandin Fgc*. could be detected in similar blood taken frcm non-treated
animals. In two experiments, combined gas chromatography and mass spectrometry
confirmed the identity of the prostaglandin FgC* . Utero-ovarian venous blood taken
frcm hysterectomised, oestrogen treated guinea-pigs did not contain any detectable
amounts of prostaglandin F^oc • This shows that the prostaglandin F^oc present in
the utero-ovarian venous blood of intact, oestrogen treated guinea-pigs originated
in the uterus and not the ovary. Neither prostaglandin F^oc nor the main guinea-
pig metabolite of prostaglandin Fg <*. (5oC, 7o^-dihydroxy-ll-oxo-tetranorprostanoic
acid) could be detected in samples analysed for their presence.
The release of prostaglandin Fgoc , a potent luteolytic substance, frcm the
uterus of oestrogen treated guinea-pigs provides a possible explanation for the
luteolytic effect of oestrogen treatment. Its presence in the utero-ovarian venous
blood correlates well with the uterine venous drainage being involved in the luteo¬
lytic effect of the uterus on the ovary. Furthermore, the absence of prostaglandin
Fgt* in the utero-ovarian venous blood of oestrogen treated, hysterectomised guinea-
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pigs is in agreement with the lack of luteolytic activity of oestrogen treatment in
such animals. Consequently the findings in this section not only provide a possible
explanation for the luteolytic effect of oestrogen treatment in guinea-pigs, but
provide also further evidence in favour of the hypothesis that the uterine luteolytic
horaone (luteolysin) is prostaglandin F2*'
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SECTION 3
Levels of Prostaglandins In the Uterine Venous Blood of Sheep
and Guinea-pig, during the Oestrous Cycle
The previous two sections have shown that the guinea-pig uterus can produce
prostaglandin F^cC, a substance known to be luteolytic, under conditions associated
with the premature release of the uterine luteolytic hormone. The pathway for tine
luteolytic action of the uterus on the ovary appears to be provided by the local
vascular system (Qxenreider and Day, 1967? Bland and Donovan, 1969 ; RLracofe et
al., 1963, 1966), Since the luteolytic hormone appears to be released from the
uterus in greater amounts towards the end of the oestrous cycle, the levels of pros¬
taglandins in the uterine venous blood of sheep and guinea-pig during the cycle have
been studied,
Methods
Collection of Blood from Sheep
Mature Cheviot ewes were checked for oestrus by pairing with a vasectomised ram
once or twice daily. The first day of acceptance was taken as day 1 of the cycle.
Laparotomies were performed on selected days of the cycle and 40 ml samples of uterine
venous blood withdrawn. A 25 ml sample and an 80 ml sample were taken, however,
from ewes on day 2 and 15 respectively. Anaesthesia was induced and maintained
with halothane and nitrous oxide. No ewe was operated on more than twice, and each
animal was killed several days after the final operation. An autopsy was performed
to ensure that the uterus and ovaries were of normal appearance. Each sample of
blood obtained wa3 centrifuged, the plasma withdrawn and extracted.
Collection of Blood from Guinea-pigs (performed by F. R, Blatchley and B,T, Donovan)
Blood was collected from the utero-ovarian vein of normal guinea-pigs on selected
days of the oestrous cycle in the same manner as described in section 2 (methods).
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Centifrugation of the blood at 4°C was carried out as soon after collection as possible
and the plasma stored at -2Q°C. After thawing the plasma frcm five guinea-pig3 on
each of the days selected was pooled so as to give volumes of 30-45 ml for extraction.
Extraction of Plasma Samples
RLasma samples obtained frcm both sheep and guinea-pigs were treated by the
solvent extraction procedure for the isolation of polar acidic lipids, as in section
1, experiment 2 (methods). The dry residues obtained were dissolved in 0.5 ml 30/2
ethyl acetate in toluene and subjected to silicic acid column chromatography, as in
section 1, experiment 5 (methods).
Silicic Acid Column Chromatography of Sheep Uterine Venous Blood Extracts
Columns of 4.2 g silicic acid (Signa SIL-R, 100 mesh} or, Bio-Rad Labs BIO
3IL A, 100-200 mesh control no. 6910 or 6583A) were used. Toluene was substituted
for benzene in the eluant mixture. The percentage of ethyl acetate in and the volume
of each fraction were the 3ame as in Table 5 (see section 1) except that fractions 3,
4 and 5 contained 65$ ethyl acetate, not 60$. This change had no effect on the elution
of prostaglandins frcm columns when prepared using Sigma SIL-R, 100 mesh or Bio-Rad labs
BIO SIL A, 100-200 mesh, control no. 6583A 3illcic acid. Prostaglandins of the "E"
series are eluted by 65$ ethyl acetate in toluene (fraction 4) and prostaglandins of
the "F" series by 80$ ethyl acetate in toluene (fraction 6) (cf. section 1, experi¬
ment 5, results). However when columns were built using Bio-Rad Labs BIO SIL A, 100-
200 mesh, control no. 6910 silicic acid, this solvent system proved unsatisfactory.
By vising authentic prostaglandins (1.5yWg each of FGE^ and of PGFgot), it was found
that a small percentage of methanol had to be added to each fraction to aid elution
of the prostaglandins frcm these columns (see results part of this section). The
percentages of solvent used in the volumes of each fraction are shown in Table 9.
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Fraction Volume (ml) Percentage
Methanol Ethyl Acetate Toluene
1 50 1 29 70
2 50 2.5 37.5 60
3 20 4 61 35
4 150 4 61 35
5 20 4 61 35
6 200 5.5 74.5 20
7 50 5.5 94.5 -
8 50 100
Table 9: Percentages of Eluant in and Volume of £ach Fraction used to
Elute Columns of Silicic Acid. Bio-Rad Labs BIO 3IL A. 100-
200 mesh, control no, 6910.
Another problem was the possible overloading of the columns with material.
This became apparent when the initial blood sample was slightly haesnolysed. It
was overcome by using larger columns (10 g) and twice as much eluant in each fraction.
The sheep uterine venous blood extracts were loaded on to the columns in a drop-
wise manner using a Pasteur pipette, and the columns eluted by the appropriate frac¬
tions of eluant. The fractions obtained from the columns were evaporated to dryness,
the residues dissolved in 1 ml water and assayed on the rat fundal strip against a
standard solution of prostaglandin (100 ng/ml).
Silicic Acid Column Chromatography of Guinea-pig Uterine Venous Blood Extracts:
Columns were prepared using 4.2 g silicic acid (Bio-Rad Labs BIO 3IL A, 100-
200 mesh, control no. 6583A) and eluted by increasing concentrations of ethyl acetate
in toluene (with no methanol added) as used for the sheep extracts. Overloading of
the columns was not a problem, therefore larger columns were not required. The frac¬
tions obtained from the columns were evaporated to dryness, under reduced pressure,
the residues dissolved in 1 ml water and assayed on the rat fundal strip. Fractions
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1-5 were assayed against a standard solution of prostaglandin Eg (100 ng/ml) whilst
fractions 6-8 were assayed against a similar solution of prostaglandin F^oC.
Gas Chromatography/mss spectrometry:
The fractions in which prostaglandin F2^ appeared, or would have appeared if
present,following silicic acid chromatography of both the sheep and guinea-pig uter¬
ine venous blood extracts, were subjected to analysis by combined gas chromatography
and mass spectrometry. After bio-assay, the appropriate fractions were evaporated to
dryness, in vacuo, the residues dissolved in methanol and transferred to 0.5 nil stoppered
tubes. The methyl ester/trimethylsilyl ether (Me/TM3) derivative of each wa3 prepared
as in section 1, experiment 5 (methods), by adding, 15yt/1 of BSTFA at the final stage
in the case of the sheep extracts and 25jul in the case of the guinea-pig extracts.
Hie Me/TM3 derivative of authentic prostaglandin Fg<x (500 and 250 ng) was also
prepared. Ten microlitre quantities were injected on to the gas chromatographic
column and the retention times noted. A mass spectrum was recorded at this time.
The Me/TM3 derivative of the appropriate fractions from the silicic columns were
then injected on to the gas chromatographic column. Mass spectra were taken of the
effluents from the column at the previously noted retention time for the Me/TMS deriva¬
tive of authentic prostaglandin Fg^ .
In addition, the methyl ester/trifluoroacetate (Me/IFA) of one guinea-pig uterine
venous blood extract was prepared by the method described in section 1, experiment 6
(methods). The Me/TFA derivative of authentic prostaglandin Fg«: wa3 al3o prepared
and its retention time on gas chromatography noted. A mass spectrum wa3 recorded at
this time. The Me/TFA derivative of the guinea-pig extract was then injected .on to the
gas chromatographic column and a mass spectrum taken of the effluent at the retention
time for the Me/TFA derivative of authentic prostaglandin Fgoc.
In two instances, fraction 4 following silicic acid column chromatography of the
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guinea-pig uterine venous extracts was biologically active. Consequently these
fractions were analysed for the presence of prostaglandins of the "E" series, by one
or both of the following methods:-
Method 1: The sample was evaporated to dryness, in vacuo, dissolved in
methanol and transferred to a 0.5 ml stoppered tube. The methyl ester was prepared as
in section 1, experiment 5 (methods), excess diazcmethane solution being vaporised to
leave a dry residue. The methoxime was then prepared by the addition of 150/JX of a
freshly prepared solution of 1$ methaxyamine hydrochloride in pyridine. After a
twelve hour reaction period the sample was evaporated to dryness, in vacuo. The
trimethyl3ilyl ether was farmed subsequently by the addition of 25jX\ B3TFA.
The methyl ester/methcodme/trimethysilyl ether (Ke/MG/TM3) of authentic prostag¬
landin (ljg) and prostaglandin (lpg) were prepared in a similar manner. Each
was injected on to the gas chromatographic column. Methoximes exist as two stereo¬
isomers which are separated by gas chromatography. Thus two peaks were obtained,
the retention time for each peak being noted far both compounds. A mass spectrum
was recorded at these times. The Me/MQ/TFB derivative of each fraction 4 was then
injected on to the gas chromatographic column. Mass spectra of the effluent from
the column were recorded at the previously noted retention times for both stereo¬
isomers of the Me/MO/TMB derivative of prostaglandins E^ and Eg •
Method 2: The sample was first evaporated to dryness, then 0,5 ml of 0.1 N
potassium hydroxide in methanol was added and allowed to stand at 37°C for 30 minutes.
Under these conditions the prostaglandin of the "E" series undergoes dehydration, with
the formation of the corresponding prostaglandin of the "A" series. This in turn is
iscmerised into the more stable prostaglandin B compound (see Figure 11).
After the reaction period, 20 ml of water was added to the reaction flask, the














The chemical conversion of prostaglandin Eg to prostaglandin Bg
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ethyl acetate. The two ethyl acetate fractions were combined and evaporated to
dryness under reduced pressure. The residue was dissolved In 0.2 ml methanol and
spotted on to a pre-prepared thin layer plate (20 cm x 5 cm) coated with silica gel
to a thickness of 0.25 mm (Kerck). An identical plate spotted with 10/^g of pros -
taglandin Bg acted as a marker. Both plates were developed simultaneously using
a solvent system of the following composition:- Toluene* 1, t-Cioxan: Acetic Acid,
25 : 15 : 0.5. A 10 cm run was allowed.
Following chromatography the marker plate was visualised by spraying with
10a' phosphamolybdic acid in ethanol and heating at 110°C far five minutes. The
Bp. value of prostaglandin 3g was noted. A zone, 1.5 cm wide with its midline
corresponding to the Bp of prostaglandin B2» was scraped off the test plate. The
silica gel was eluted by shaking with 5 ml methanol. The resultant suspension was
centrifuged and the methanol withdrawn. This was repeated with another 5 ual of
methanol. The two methanol fractions were then combined, reduced in volume by low
pressure evaporation, transferred to a 0.5 ml stoppered tube and finally evaporated
to dryness. The Ke/TfG derivative of the residue was then formed as in section 1,
experiment 5 (methods).
The Fe/TM3 derivative each of 1^ g of prostaglandins and was also prepared.
These were injected on to the gas chromatographic colvmn and their retention times
noted, (column temperature » 195°C). A mass spectrum of each was recorded. The
Ke/U0 derivative of the extracted material was then injected on to the column and
mass spectra recorded at the noted retention times.
Recovery Experiments
a) From Sheep Blood* During some of the operations on the ewes, a peripheral
sample of blood (A0-A5 ml) was taken from the jugular vein. To this was added
sufficient prostaglandin to produce a final concentration of 10 ng/ml. To one
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jugular venous sample from a sheep on day 15, prostaglandin was not added. These
samples were treated exactly as described above. They provided estimates as to the
percentage recovery of prostaglandin F^cx from sheep's blood, and the reliability of
the extraction and isolation process as a vfoole.
b) From Guinea-nip; Blood;
i) The percentage recovery of prostaglandin from guinea-pig blood was
determined in section 2. The result obtained there (45.5&) has been used in these
experiments to calculate levels of prostaglandin in uterine venous blood of
guinea-pigs.
ii) The percentage recovery of prostaglandin Eg from guinea-pig blood was
determined in a similar manner to that of prostaglandin F^oc described in section 2.
Three guinea-pigs were killed, their necks incised and blood allowed to drain from
the wounds into heparinised vessels. Quantities of 10 to 16 ml were obtained and
sufficient prostaglandin E^ added to produce concentrations of 10, 30 and 50 ng/ml.
After standing for one hour, each blood sample was centrifuged and the red cells
discarded. The plasma was treated as described earlier. The percentage recovery
of prostaglandin Eg from the guinea-pig blood was calculated from the bioassay results
obtained.
Results
1) Column Chrcmatopraphy of the Authentic Prostaglandins U3ing Bio-Rad Labs
BIO 31b A 100-200 mesh control no. 6910 silicic acid
Table 10 summarises the bioassay results obtained. Prostaglandin E^ was





























































Table 10: Results of the Column Chromatography of Authentic Prostaglandins
Using Bio-Rad Labs BIO SIL A. 100-200 mesh Control no. 6910
Silicic Acid, A Small Percentage of Methanol has been added
to each Fraction to aid Elutlon
Prostaglandins subjected to column chromatography using thi3 particular batch
of silicic acid -without the addition of methanol to each fraction were not eluted
from the columns until the final methanol stage and separation of the different series
of prostaglandins was not achieved. Consequently by adding a small percentage (1-5.5$)
of methanol, the polarity of solvents in each fraction wa3 increased sufficiently to
elute prostaglandins from the column and to achieve a separation.
2) Sheep Blood Extracts
The oestrous cycle in all nine ewes was 17 days in length. The operational
procedure had no effect on the recurrence of oestrus although in two ewes behavioural
oestrus was either weak or absent. This was probably due to the close proximity of
the end of the breeding season. At autopsy the uterine horns and ovaries appeared
normal. Consequently there was no reason to believe that the collecting of uterine
and peripheral blood samples had affected the sheep in any way.
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i) Recovery Experiments: The last column of Table 11 shows the percentage
recovery of added prostaglandin F^e* from jugular venous blood. Gas chromatography












Average % Recovery 46.7
Table 11: Percentage Recovery of Prostaglandin from the Peripheral
Venous Blood of 3heep at a Concentration of 10 ng/ml
The average percentage recovery was 46.7$ (range 42.5$ to 53.3$). No prostag¬
landin Fgc< (<2.9 ng/ml) could be detected in the peripheral venous blood, taken from
a ewe on day 15, to which prostaglandin Fgoc had not been added.
ii) Levels of Prostaglandin in the Uterine Venous ifrood of Sheep:
The estimated levels of prostaglandin Fgo< in the uterine venous blood taken
from the ewes during the oestrous cycle and corrected for a 46.7$ recovery are shewn
in the last column of Table 12. These figures are based on the combined evidence
of bioassay, ga3 chromatography and mass spectrometry.
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Ewe Day B'ioassay Result Mass Estimated Level
No. of (Total Activity Spectrometry of PGFp*. in
Uterine venousCycle Extracted Result
= ng FGFgoc ) Blood (ng/ml)
2 2 <35 Possible Trace < 3.0
8 4 <50 n.d. <2.7
2 7 <50 n.d. <1.9
10 7 50-75 n.d. < 2.7
10 9 <50 n.d. <2.7
3 10 180-200 Possible Trace <2.7
12 11 <50 n.d. <2.7
5 13 <50 n.d. <2.7
3 14 135-165 PGFg^ present 7.2-8.86 15 115-135 6.1-7.2
11 15 120-130 FGFp^ present
FGF^ present
3.2-3.5
4 16(a) 90-120 4.8—6.4
4 16(b) 60-80 3.2-4.3
n,d, means no FGFpC* detected.
—- means PGFg'* P®8*® 11133^ed by interfering substances.(a) and (b) are from different cycles.
Table 12: bevel of Prostaglandin F qc (FGF q< ) in the Uterine Venous Blood
of 3heep during the Pestyous (^cb9
Frcm day 2 to day 13, no prostaglandin F^ot (<3 ng/ml) could be identified in
uterine venous blood, whereas on days 14, 15 and 16 the estimated levels ranged frcm
3.4 to 8.0 ng/ml. In ewe 10 (day 7) and ewe 3 (day 10) there was smooth muscle
stimulating activity in the appropriate fraction frcm the silicic acid column, but
this was not due to prostaglandin F^c* as shewn by the results of gas chromatography
and ma® spectrometry. However, a possible trace amount may have been present in
ewe 3 (day 10) and in ewe 2 (day 2). This was based solely on the existence in the
mass spectra of very small peaks at m/e values of 494 and 513. These two peaks are
characteristic of the Me/TMS derivative of prostaglandin f^ o< • The levels they
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represented were probably less than 15 ng. Approximately 50-100 ng of prostaglandin
Fgoc is needed for conclusive mass spectral evidence to be obtained when interfering
substances are present in extracts of biological material. The amount required
depends upon the purity of the final extract. This was evident in ewe 6 (day 15)
aid ewe 4 (day 16b). The final extract obtained contained unusually large amounts
of interfering substances. Thus conclusive mass, spectral confirmation could not be
obtained.
Examples of the evidence provided by gas chromatography and mass spectrometry
are shown in Figure 12. The retention time of the Fjie/TMS derivative of prostaglandin
was 19.5 minutes. The line diagrams represent, for each sample, mas3 spectra
taken at this time of the effluent from the gas chromatographic column. Any peaks
characteristic of the Me/TFS derivative of authentic prostaglandin F^oc of m/e value
below 400 were lost in the background noise. Therefore the identification of pros¬
taglandin Fgin the samples was based on the presence in the mass spectrum of the
six peaks at m/e values of 404, 423, 494, 513, 569 and 584. These were present, in
the correct ratios, in the trace obtained from ewe 3 (day 14), but were not present
in the trace obtained frcra ewe 2 (day 7). The uterine venous blood extracts from
both gave five other peaks which were not found in authentic prostaglandin Fgx. *
These are due to a common impurity. This evidence shows that prostaglandin FgC<
is present in the uterine venous blood taken on day 14, but not in the uterine
venous blood taken on day 7. Similar conclusions were drawn regarding other samples.
3) Guinea-pig Blood Extracts;
i) Recovery Experiment; The percentage recoveries of prostaglandin E2
from guinea-pig blood at concentrations of 10, 30 and 50 ng/ml were 42.5$, 46.4$
and 47.5$ respectively, the average recovery being 45.5$. These figures are based
solely on the bioassay result obtained on the rat fundal strip following solvent
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Day t4 (Ewe 3)
400 420 440 460 400 500 520 540 560 300600
•%
420 440 460 300 320 540 560 5S0
Authentic Prootagtandin p2« (Me/TMS)
09*1»9O
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■5}
Fig. 12
Line diagrams of mass spectra (m/e peaks greater than 400) of the Me/TMS
derivative of material extracted frcm uterine venous blood samples taken
from sheep on day 14 and day 7, and of authentic prostaglandin «
Ordinate: percentage relative intensity of peaks.
Abscissa: m/e value of peaks.
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extraction and silicic acid column chromatography of the blood samples. The recovery
of prostaglandin FgO< from guinea-pig blood was 45.5$ also (see section 2, results),
ii) Levels of Prostaglandins in the Utero-ovarian Venou3 Blood of Guinea-pirs.
The estimated levels of prostaglandin FgO< and Eg in the utero-ovarian venous blood of
guinea-pigs during the oestrous cycle are shown in Table 13. These figures are based
on the bioassay results and are corrected for recoveries of 45.5$ for prostaglandin F^oc
and for prostaglandin Eg. The level of prostaglandin Fgc< on day 7 has been taken
from the results obtained in section 2 for the non-treated, intact groups of guinea-
pigs and represents the average value recorded. No figure for the level of prostag¬
landin Eg on day 7 has been included, since in those experiments, the fraction from
the silicic acid columns in which prostaglandins of the "EH series would appear, if
present, was assayed in terms of prostaglandin E^, However, no prostaglandin E-like
activity was detected.
Day of Cycle Level of PGFp0< Level of FGE_
(ng/ml) (ng/ml)









Table 13: Levels of Prostaglandin F^oc(FGFgOC) and Prostaglandin EL (PGBg)
In the Utero-ovarian Venous BlooS of Guinea-pigs during the
Oestrous Cycle. Blood from 5 Guinea-pigs was pooled for Each Day
The level of prostaglandin FgC< on day 3 was 14.1 ng/ml. This has fallen to
below detectable limits (<3.3 ng/ml) on day 7. On days 9 and 10, low levels (5.2
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and 3.5 ng/ml) were present. The levels subsequently rose to values between 15.7
and 17.2 ng/ml on days 11, 12, 13 and 14. A large ri3e then occurred to a level of .
60.7 ng/ml on day 15. After this peak, the level of prostaglandin F^ot must have 3oon
started to decline as the level on day 3 reflected.
Prostaglandin Eg wa3 not detected in the utero-ovarian venous blood of guinea+pigs
examined on days between 3 and 12. A detectable level, 1.1 ng/ral, was present on day
13 which rose to 5.4 ng/ml on day 14. The level then increased sharply to 54.9 ng/ml
on day 15. A fall then set in as the level on day 3 reflected.
Identification of the Prostaglandins
a) Prostaglandin F^oc: Gas chromatography and mass spectrometry provided
conclusive evidence fear the presence of prostaglandin F^oc in several of the guinea-
pig blood samples. The Me/TFB and Me/TFA derivatives of authentic prostaglandin Fgo<
on gas chromatography had retention times of 16.6 and 4.9 minutes, respectively. Mass
spectra were taken at these times of the column effluent of the Me/TMS and Me/TFA
derivatives of material extracted from blood taken from day 15 guinea~pig3 (see Figure
13). The spectrum of the Me/TMS derivative contains significant peaks at m/e values
of 307, 333, 353, 379, 404, 423, 494, 513, 569 and 584, the peaks typical of those
produced by the Me/TMS derivative of authentic prostaglandin Fgo< . The ratio between
peak heights is approximately the same also. Similarly the mass spectra of the Me/TFA
derivative of extracted material and authentic prostaglandin Fg«>< have peaks in common
at m/e values of 314, 428, 441, 511 and 542, again in approximately the same ratios.
Thi3 confirms that prostaglandin Fgo< was present in the utero-ovarian venou3 blood
of guinea-pigs taken on day 15 of the cycle. Similar evidence, based on a comparison
of the mass spectra of the Me/TMS derivatives, confirmed the presence of prostaglandin
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Line diagrams of mass spectra (m/e peaks greater than 300) of the Me/TMS
and Me/TFA derivatives of material extracted from the utero-ovarian venous
blood taken from guinea-pigs on day 15, and of authentic prostaglandin Fgcx*
Ordinate: percentage relative intensity of peaks.
Abscissa: m/e value of peaks.
The mass spectra of the Me/TM3 derivative of the extracted material obtained frcm
guinea-pigs on days 3, 9, 11 and 12 contained many peaks. This was due to the presence
of large quantities of interfering substances. Consequently any "prostaglandin peaks"
present in the spectra were masked. It was therefore not possible to obtain mass
spectrcmetric confirmation for the presence of prostaglandin F^oc on day3 3, 9, 11
and 12.
The mass spectrum of the Me/TMS derivative of the material extracted on day 10,
which was reasonably free from contaminating peaks, did not contain the peaks typical
of authentic prostaglandin F^cx. (Me/TMS). However, the amount remaining after bio-
assay (70 ng) may have been below threshold for detection, since only 30 to 40 ng was
injected on to the gas chromatographic column.
b) Identification of Prostaglandin E^: Gas chromatographic/mass spectrcmetric
identification of prostaglandins of the "E" series extracted from the blood samples
collected on days 14 and 15 proved difficult. The whole of the material extracted
on day 14 and two-thirds of that extracted on day 15 were analysed by method 1 (see
methods). The Me/MO/TMS derivative of prostaglandins and Eg on gas chromatography
had retention times of 18.4 and 14«& minutes for the first isomer and 22.3 and 18.4
minutes for the second isomer, respectively. Mass spectra taken at these times of
the effluent from the column of the Me/MQ/TK3 derivative of the extracted material
obtained frcm guinea-pigs on days 14 and 15 contained many large contaminating peaks,
again masking any "prostaglandin peaks" which may have been present. Therefore, no
conclusions could be drawn.
However, the analysis of the remaining material extracted on day 15 by method 2,
which involved conversion to the corresponding prostaglandin B proved more successful.
On thin-layer chromatography (TLC) authentic prostaglandin had an Rp value of 0.37,
On gas chromatography, the Me/TMS of prostaglandins and each had a retention
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time of 17.2 minutes. The mass spectrum of prostaglandin (Me/TKi) showed three
significant peaks at m/e values of 323, 351 and 422, in the ratio of 4 : 1 : 1 vdiereas
prostaglandin Bg (Me/TM3) had significant peaks at 321, 349 and 420, again in the ratio
4:1:1. The two mass unit difference is accounted for by the 5#6 double bond in
the prostaglandin Bg molecule. The peaks at 422 and 420 are the molecular ions of
the Me/TK3 derivative of prostaglandins B^ and Bg respectively.
The remaining one third of the prostaglandin E-like material extracted on day 15
was converted to the prostaglandin B compound by the method described (see methods).
After TLC, the zone of silica gel 1.5 cm wide, which approximated to an Rp value of
C.37 was scraped off the plate and eluted. The material extracted, after conversion
to the Me/TMS, was analysed by gas chromatography. A mass spectrum taken of the
effluent at 17.2 minutes, contained peaks at m/e values of 321, 349 and 420, in the
ratio of 4 : 1 : 1. These are the peaks in the ratio characteristic of prostaglandin
Bg(Me/TMS). However, these three peaks, although clearly visible, were very much
smaller than many other peaks in the spectrum. It was of significance, however, that
there were no peaks at m/e values of 323, 351 and 422 (corresponding to prostaglandin
V- On this evidence it can be concluded that small amounts of prostaglandin Bg
were present, whereas no prostaglandin B^ could be detected. This prostaglandin Bg
could have been formed only from prostaglandin Eg present originally in the blood
which, following solvent extraction, was eluted from the silicic acid columns by 65$
ethyl acetate in toluene (fraction 4). Any prostaglandins of the "A" or "B" series
which may have been present originally would have been eluted from the silicic acid
columns by fractions 1 and 2 (30$ and 40$ ethyl acetate in toluene) (Lee et al, 1967).
It can be concluded that prostaglandin E-like material present in the utero-ovarian




The results in this section have shown a variation in the level of prostaglandin
Fgt* in the uterine venous blood of sheep and a similar variation in the levels of
prostaglandins Fgc< and Eg in the utero-ovarian blood of guinea-pigs. In sheep,
prostaglandin F^c* was present in the uterine venous blood towards the end of the
oestrous cycle (days 14, 15 and 16). The levels ranged from 3.3 to 8.0 ng/ml.
No prostaglandin Fgtx was detected in the uterine venous blood at any stage earlier
in the cycle. Furthermore, prostaglandin Fgoc was not present in the venous blood
taken frcm the jugular vein of ewe 11 on day 15, whereas the uterine venous blood on
that day contained 3.3 ng/ml.
In sheep with normal oestrous cycles, the progesterone level of the corpus luteum
falls sharply on day 15 with complete regression on day 16 (Deane, Hay, Moor, Rowson
and Short, 1966). Since the local vascular system provides the pathway for the lute-
olytic action of the uterus on the ovary (Kiracofe et al, 1963, 1966), the presence of
a luteolytic substance in the uterine venous blood shortly before day 15 would be
expected. The observation that prostaglandin F^oc is present in the uterine venous
blood on days 14 to 16, and at no other time, supports this hypothesis.
This presupposes that luteolysis induced by prostaglandin Fg<x is a rapid process.
The observations of Deane et al, (1966) necessitate this to be the case. The lute¬
olytic effect of prostaglandin Fgtx is, in fact, quick in onset, for the level of
progesterone in the ovarian vein falls within one hour after the start of a continu¬
ous infusion (50/tg/hr) of prostaglandin Fg<x through the ovarian artery (McCracken
et al, 1970). A fall in progesterone levels occurs also with infusion rates of 0.01
and l.Oyu-g/hr, levels in keeping with the present findings.
An increase in the level of a luteolytic substance in the venous drainage from
the uterus towards the end of the oestrous cycle in the guinea-pig would also be
expected. The elevated level (60.7 ng/ml) of prostaglandin found in the utero-
ovarian venous blood taken from the guinea-pig on day 1$ supports this view. (In
section 2, the prostaglandin FgOr in the utero-venous blood was shewn to originate
from the uterus and not the ovary. Its release from the uterus ha3 been assumed
here). The level on day 15 in the guinea-pig (60.7 ng/ml) was much higher than
that on the same day in the sheep (average value, 5.2 ng/ml). In addition, prostag¬
landin Fgoc wa3 present in the utero-ovarian venous blood of guinea-pigs at earlier
times in the cycle, although in levels much lower than that on day 15. There was a
rise from below a detectable level on day 7 (<"3.3 ng/ml) to levels of 5.3 and 3.5 ng/ml
on days 9 and 10. A further rise occurred to levels between 15.7 and 17.2 ng/ml on
days 11 to 14 before the large rise to the level on day 15.
It i3 of note that the corpora lutea in the ovaries of guinea-pigs have attained
maximum size by day 10 after which no increase in size normally occurs. hysterec¬
tomy performed on day 10, however, always results in a further increase in corpora
luteal size (Rowlands, 1961). Thus the presence of the uterus after day 10 exerts
a limiting effect on the size of the corpora lutea. It may therefore be of some
consequence that a rise in the level of prostaglandin F^oc in the utero-ovarian venous
blood of guinea-pigs occurs between days 9 and 10. A level of 15 to 17 ng/ml may be
sufficient to restrict corpora luteal size but inadequate to cause appreciable regres¬
sion. Also hysterectomy of the guinea-pig before the 14th day of the oestrous cycle
allows the maintenance of the corpora lutea, whereas if this procedure is perforated
on or after the 15th day the corpora lutea usually regress at the normal time (Rowlands,
1961; Bland and Donovan, 1969). Therefore, the luteolytic action of the uterus in
the guinea-pig apparently takes effect between days 14 and 15 of the cycle. This
coincides exactly with the large increase in level of prostaglandin F^c* which occurs
in the utero-ovarian venous blood of guinea-pigs between those two days.
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The utero-ovarian venous blood samples collected from guinea-pigs and analysed
for prostaglandin in this section were analysed also for progesterone. This was
performed by F, R. Blatchley and Dr, B. T. Donovan using a competitive protein
binding technique based on the method described by Johansson (1969). The level of
total extractable progestins was measured in terms of progesterone. The results




( = ng Progesterone/ml - 3e)
3 65.9 ~ 12.3
9 126.0 7 31.0
10 108.2 J 15.2
11 94.9 7 37.9
12 177.2 7 31.8
13 81.1 7 22.1
14 105.9 7 30.0
15 45.1 - 10.0
Table 14: Level of Total Extractable Progestin (sng Progesterone/ml)
in The Plasma of Utero-ovarian Yenou3 Blood of Guinea-pigs (n ■ 5)
during the Oestrous Cycle. The Baseline Value (i,e. the mean
level fran Guinea-pigs with no Corpora Lutea in the appropriate
ovary) wa3 40 ng/ml. (Results supplied by F, R, Blatchley and
B. T, Donovan)
The large variation and standard errors are due mainly to the fact that some
guinea-pigs had no corpora lutea in the ovary on the side from which blood was taken.
However, a trend is apparent. On day 3, when the oarpora lutea are still increasing
in size, the plasma progestin level is equivalent to 65.9 ng progesterone/ml. At
this time the prostaglandin Fgtx. level i3 14.1 ng/ml, a level of same possible signifi¬
cance, although it is declining fran the peak level at the end of the previous cycle.
On day 9, progestin levels have increased to an equivalent of 126 ng progesterone/ml.
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They remain high up to day 14. However, between days 14 and 15 there is a sudden
fall from 105 ng/ml to 45.1 ng/ml. This fall is in parallel with the large rise in
prostaglandin F^oc level which occurs at the same time. Consequently, the fall in
progestin levels from the ovaries may be the result of the increase in prostaglandin
FgoC level from the uterus.
The variation in the level of prostaglandin E^ which occurs in the utero-ovarian
venous blood of guinea-pigs towards the end of the oestrous cycle merits comment. The
level frcm days 3 to 12 is less than 0,8 ng/ml, Two small rises occur to levels of
1,1 and 5,4 ng/ml on days 13 and 14 respectively, A large rise then occurs to a
level of 54.9 ng/ml on day 15. Pharriss has reported that prostaglandin Eg is luteo-
lytic in all mammalian species of laboratory animal (see McCracken, 1971). Conse¬
quently the prostaglandin Eg may be acting synergisticslly with prostaglandin Fgoc
to cause luteolysis. However, several observations do not correlate with this theory.
Prostaglandin Eg was not detected in the utero-ovarian venous blood of guinea-pigs
receiving oestrogen treatment (see section 2) nor in the uterine venous blood of sheep
where prostaglandin Fgcx. was present. Also prostaglandin Fgc* alone will cause
progesterone levels to fall and 20o< -dihydbroprogesterone levels to rise in both the
rat and sheep ovary (Pharriss et al, 1969; McCracken et al, 1970). It has been
assigned that the prostaglandin Eg found in the utero-ovarian venous blood of guinea-
pigs at the end of the oestrous cycle originated in the uterus. However, it may
have cane from the ovary. Prostaglandins are produced by the ovary (Speroff and
Ramwell, 1970) and in the rabbit ovary this is chiefly prostaglandin Eg (Bedwani,
1970), Since prostaglandin E^ is luteotrophic in vitro (Speroff and fiamwell, 1970)
its presence may be connected with the impending ovulation which initiates the next
cycle. However prostaglandin F^c* is luteotrophic in vitro, also (Speroff and
Ramwell, 1970). Thus the presence of a high level of prostaglandin Eg in the utero-
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ovarian venous blood of guinea-pigs on day 15 is far from clear.
The results in this section have demonstrated an elevated level of prostaglandin
Fgtx in the venous drainage from the uterus near the end of the oestrous cycle in both
the sheep and guinea-pig. These observations add further support to the view that
the uterine luteolytic hormone is prostaglandin F2oc.
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3 £ C T ION 4
Identification of Prostaglandin F^c< in Uterine Fluid frcm Mora-Pregnant
Sheep Bearing an Autotransplanted Ovary
Allotransplantation of the ovary or uterus to the neck in sheep causes the
persistence of the corpus luteum and high progesterone levels due to the separation
of the ovary from the local luteolytic control of the uterus (Goding et al, 1967a,b).
In some sheepy fluid accumulates in the uterus over a period of several months. This
fluid has been aspirated at laparotomy, under sterile conditions, and analysed for
the presence of prostaglandins.
Methods
Four Merino X welsh Sheep were used in this studyj-
1) Collection of Uterine Fluid (performed by f. A. Harrison and ri« beaP),
a) Previous History of Sheep: Three of the four sheep had undergone
right ovariectomy, right adrenalectomy and left adrenal transplantation. After
fertile mating, the left ovary was transplanted to the neck (January to March, 1968}
33 to 40 days, post coitum). Two sheep delivered single lambs successfully after
146 and 148 days gestation, but in the third abortion occurred 13 days after trans¬
plantation of the ovary. During the next 2-3 years oestrus was observed in one
sheep only on one occasion. In all three animals, blood progesterone levels indi¬
cated the presence of persistent corpora lutea. In a fourth sheep, which was non¬
pregnant, the left ovary was transplanted whilst the right ovary removed intact.
Oestrus was subsequently detected once only and a persistent corpus luteum was found
when the transplant was removed 232 days after ovulation. Thereafter, normal cyclic
activity of the intact right ovary wa3 observed at the next breeding season.
b) Withdrawal of Fluid from the Uterus: Laparotomies were performed on
the first three sheep up to three years after ovarian transplantation and after 179
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days following the transplant operation in the fourth sheep. Fluid present in
the uterus was aspirated by a syringe, aliquots taken for bacteriological examina¬
tion, and the remainder stored at -15°C until extracted.
c) Collection of Uterine Venous and Peripheral Arterial Blood: In one
sheep, in addition to withdrawing the uterine fluid, one sample each of uterine
venous and carotid arterial blood were taken at laparotomy. The blood samples were
centifuged, the plasma withdrawn and frozen at -15°C until extracted.
Volume of Uterine Venous Plasma » 10.0 ml
Volume of Carotid Arterial FLasma » 13.0 ml
2) a) Extraction of Uterine Fluid: Ihe method used was a modification of
the procedure employed for the isolation of acidic polar lipids described in section
1, experiment 2 (methods). The uterine fluid was adjusted to pH 4 with hydrochloric
acid and partitioned twice with three volumes of ethyl acetate. "Hie ethyl acetate
fractions were bulked, washed with a small quantity of water and evaporated to dryness
under reduced pressure. The residue was partitioned between 25 ml 67$ ethanol and
25 ml petroleum spirit (b.p. 40° - 60°C). The petroleun was washed with a further
25 ml of 67$ ethanol, the ethanol fractions combined and evaporated to dryness. The
residue was dissolved in 0.5 ml 30$ ethyl acetate in toluene and subjected to silicic
acid column chromatography.
b) Extraction of Plasma Samples; The plasma samples were extracted by the
solvent extraction procedure described in section 1, experiment 2 (methods). Hie
final dry residues were dissolved each in 0.5 ml 30$ ethyl acetate in toluene and
subjected to silicic acid column chromatography.
3) Silicic Acid Column Chromatography: Columns of 4.2 g silicic acid (Sigma
3IL-R, 100 meshj or Bio Bad Labs BIO 3IL A, 100-200 mesh, control no. 6910) were
used. The solvent systems employed were the same as those described in section 3
(methods), the correct one being used for the appropriate batch of silicic acid.
Fractions obtained from the columns were evaporated to dryness, the residues dis¬
solved in 1 ml of water and assayed on the rat fundal strip. Fractions 1-5 were
assayed in terms of prostaglandin Eg, fractions 6 - 8 in terms of prostaglandin
4) Gas Chromatography/Mass Spectrometry: The appropriate fraction (fraction
6) fran the silicic acid columns in which prostaglandin FgC* would be expected to
appear, was analysed, following bioassay, by combined gas chromatography and mass
spectrometry. The methyl ester/trimethylsilyl ether (Me/TM3) was prepared as in
Section 1, experiment 5 (methods), in every case. The Me/TM3 of authentic prostag¬
landin Fgc* was prepared for reference purposes as before. In addition, the methyl
ester/trifluoroacetate (Me/fFA) of the extracted material from the uterine fluid and
of authentic prostaglandin Fgcx was formed in one case.
The authentic prostaglandin F^oc derivatives were injected on to the gas chroma¬
tographic column and the retention time3 noted. A mass spectrum was taken at the3e
times. The Me/TMS and Me/TFA derivatives of fraction 6 from the silicic acid columns
were injected on to the gas chromatographic column also. Where appropriate, a mass
spectrum of the effluent from the column was taken at the previously noted retention
times for the authentic prostaglandin FgC< derivatives.
The temperature of the gas chromatographic column was 195°C for the Me/TMS
derivatives and 190°C for the Me/TFA derivatives. Other conditions were the same
as in section 1, experiment 5, (methods).
Results
1) Condition of the Uterine Fluid and Uterus (performed by F. A. Harrison
and R. B. Heap)
The fluid recovered from all four sheep was viscous, odourless and sterile.
The amounts withdrawn ranged from 10 to 1900 ml. Biopsy specimens taken fran the
uterine wall at operation revealed an intact, tall columnar epithelium and an
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appreciable development of the uterine gland epithelium* The histological
features were characteristic of the luteal phase of the normal cycle.
2) Levels of Prostaglandins in the Uterine Fluid
Prostaglandin oc was detected in the uterine fluid taken frcm all four sheep.
The levels ranged frcm 15 ng to 4y"g PGFgC><./ml (see Table 15). The total amounts
ranged frcm 150 ng to 7.6 ntg. These figures are uncorrected for recovery. The
highest concentration of prostaglandin Fg <*. was found in a sheep adrenalectomised
5 days earlier. This sheep produced the largest amount of uterine fluid too.
No prostaglandins of the "E" series (< 1 ng PGE^/ml) were detected.








Table 15: The Level of Prostaglandin F « in the Uterine Fluid of
Four Sheep with Autotransplanted Ovaries.
Gas chromatography and mass spectrometry confirmed the presence of prostaglandin
Fgoc. in each sample of uterine fluid. The retention time for the fae/TMS derivative
of authentic prostaglandin Fgot was 19.5 minutes. The Me/TFB derivatives of the
uterine fluid extracts produced a gas chromatographic peak at this time. The reten¬
tion time for the Me/TFA derivative of prostaglandin F^oc was 5.3 minutes. The




Results of the gas chromatography of the Me/TMS and Me/TFA derivatives of
material extracted from uterine fluid taken from a sheep with a transplanted
ovary, and of authentic prostaglandin F-<x • Ordinate: recorder response
(200 mv full-scale). Abscissa: time In minutes.
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Mass spectra were recorded of the effluent frcm the column at these retention
times in all cases. Figure 15 represents one 3et of results obtained. The Me/TMS
derivative of extracted material and prostaglandin have significant m/e peaks
at exactly the same values of 307, 333, 353, 379, 404, 423, 494, 513, 569 and 534.
Similarly the Me/TFA derivatives have common peaks at m/e values of 314, 428, 441,
511, and 542. This evidence shows conclusively that the material extracted frcm
the uterine fluid is prostaglandin F^oc . Similar results were obtained with all
four samples of uterine fluid.
3) Plasma Levels of Prostaglandins in Uterine Venous and Carotid
Arterial Blood
Prostaglandin F-like activity was detected in the uterine venous blood of one
sheep studied, the level ranging frcm 8.0 - 10.0 ng PGF^oc/ml plasma. No prostag¬
landin F-like activity was detected in carotid arterial blood (<3.9 ng FGFgfik/ml
plasma). Hcwever, the amount extracted from the uterine venous blood and which
remained after bioassay ( =50-70 ng prostaglandin Fg<x ) proved insufficient for
positive identification by gas chromatography and mass spectrometry.
Conclusion
During the normal oestrous cycle of the sheep, there is little fluid in the
uterine lumen at any time of the cycle. However, where the ovary and uterus have
been surgically separated by autotransplantation of the ovary, large quantities of
viscous, sterile fluid accumulate in the uterus of most sheep. This fluid has now
been found to contain a high concentration of prostaglandin f2*. Its presence could
not be attributable to tissue breakdown since the uteri in all four sheep were in
excellent condition. The endcmetria were in the luteal phase of the normal cycle.
Also prostaglandin Eg, which is formed frcm the same precursor as prostaglandin
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Abscissa: /e value of peaks.
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cause (see section 5). Therefore, the large amounts present probably reflected a
high secretion rate of prostaglandin F^c* by the uterus.
Prostaglandin F^-like material was present in the uterine venous blood, but
its identification was not conclusive. In the guinea-pig, prostaglandin can
pass from the uterine lumen into the venous blood (see section 5). Therefore it
is likely that the endogenous prostaglandin F^u. in the sheep will reach the blood
by a similar mechanism. No prostaglandin FgX. -like material could be detected in
the peripheral arterial blood. This can be attributed to the efficient removal of
prostaglandins from the circulation by one passage of the blood through the lungs
(Ferreira and Vane, 1967).
It is therefore apparent that in these sheep the situation had been established
where the uterus was secreting, a high level of a luteolytic substance (prostaglandin
Fgoc), which, although present in the uterine venous drainage, was being prevented
by the lungs from reaching the transplanted ovary in concentrations adequate to cause
luteolysis. Thus, in the absence of an effective luteolysin, the corpus luteum in
the transplanted ovary persisted and progesterone levels remained elevated. It is
significant that in an experiment where the uterus and ovary together were autotrans-
planted to the neck without disruption of the local luteolytic control, regular
oestrou3 cycles were maintained (Harrison et al, 1968). The accumulation of fluid
in these experiments resembles the condition of hydrometra f ound in seme other species.
In rodents, the condition is commonly related to chronic oestrogenisation (Deanesly,
1966) whilst in the dog it has been attributed to a progesterone excess arising from
a persistent corpus luteum (Dow, 1957, 1959). Consequently, it i3 probable that
high levels of oestrogen and/or progesterone account for the accumulation of fluid
in the sheep uterus. The high level of secretion of prostaglandin F^oc may be
attributable to these hormones al3o, especially since oestrogen treatment in the
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guinea-pig has been shown to cause the release of prostaglandin F^e*. from the uterus
(see section 2). The results obtained in these experiments tend to support the
hypothesis that prostaglandin F^cx. is the uterine luteolytic hormone (luteolysin).
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3, E C T I 0 N 5
The Production of Prostaglandins by the Guinea-pig Uteru3
The results in sections one, two and three have shown that prostaglandins are
released from the guinea-pig uterus. In this section, the ability of the guinea-
pig. uterus to produce prostaglandins has been examined. Some of the factors which
may effect the production of prostaglandins by the uterus have been studied. Initially
however, the resting levels of prostaglandins in the uterus were measured.
Methods
Guinea-pigs used in the following experiments were smeared daily, as in section
1, experiment 1 (methods). Day 1 of the cycle was the day preceding the post-
ovulatory influx of leucocytes when cornification of the vagina was at a maximum.
All guinea-pigs used had exhibited cycle lengths of 16 or 17 days.
1) Homogenisation of Guinea-pig Uterus in Absolute Ethanol
a) Three guinea-pigs on each of days 3, 6, 9 and 11 to 15 of the cycle were
killed, by stunning and incising the neck, and their uteri removed. Each uterus
was weighed, cut into small pieces and homogenised in 5 ml of absolute ethanol, using
a Fison's glass homogeniser. The hcmogenate was poured into a 25 ml flask and the
homogeniser washed with two further 5 ml portions of ethanol. The washings were
added to the hcmogenate in the flask. During the next 90 minutes, each flask was
occasionally shaken. At the end of this period, each hcmogenate was evaporated to
dryness under reduced pressure. The resultant residues were resuspended in 10 ml
of water, adjusted to pH4 with hydrochloric acid and solvent extracted. The three
extracts obtained far each day were combined and subjected to silicic acid column
chromatography.
b) Two guinea-pigs, one on day 6, the other on day 9, were killed, their uterine
horns removed and separated. The right horn from one was paired with the left horn
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frcm the other. After weighing, each pair was cut into small pieces and homogenised
in ethanol as j\ist described. To one homogenate was added 400 ng each of prostag-
landins and Fgoc . Both homogenates were allowed to stand for 90 minutes, with
occasional shaking, then evaporated to dryne33 under reduced pressure. The residues
were resuspended by the addition of 10 ml of water, sufficient hydrochloric acid was
added to lower the acidity to pH4, and the acid aqueous suspension was then solvent
extracted. This was followed by silicic acid column chromatography of the two
extracts.
2) Homogenisation and Incubation of Guinea-pip Uterus in Tyrode'3 Solution
Three guinea-pigs on each of days 3, 6, 9 and 11 to 15 of the cycle were killed,
their uteri removed and weighed. Each uterus was cut into small pieces and homogenised
in 5 ml of Tyrode's solution in a glass homogeniser. Homogenisation was complete in
5 minutes. The hcmogenate was poured into a 25 ml flask, the homogeniser washed with
three further 5 ml portions of Tyrode's solution and the washings added to the fla3k.
Each hcmogenate was bubbled with oxygen and incubated at 37°C for 90 minutes. Follow¬
ing incubation, the hcmogenate was adjusted topH4 with hydrochloric acid and solvent
extracted immediately. The three extracts obtained for each day were combined and
subjected to silicic acid column chromatography.
3) Hcmogenisation of Guinea-pig Uterus in Ice-cold Water
A guinea-pig on day 6 of the cycle was killed, the uterus removed and weighed.
The uterus was then cut into small pieces and homogenised in 5 ml ice cold water.
The homogeniser was surrounded by an ice bath and hcmogenisation was complete in
five minutes. The hcmogenate produced was adjusted to pH4, solvent extracted
immediately and then subjected to silicic acid column chromatography.
4) Hcmogenisation of Guinea-pig Uterus and Incubation in Kreb's Solution Containing
Arachidonlc Acid
Six guinea-pigs on day 6 of the cycle were used. Each guinea-pig was killed, the
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uterus removed and horns separated. bach horn was weighed, cut into small pieces
and homogenised in 5 ml Kreb's solution,previously bubbled with 95^ oxygen# 5% carbon
dioxide, within 5 minutes. bach horaogenate was poured into a 25 ml flask, the
homogeniser washed with a further 5 ml portion of Kreb's solution and the washings
added to the flask. To the 10 ml homogenate of the left uterine horn from two
guinea-pigs and the right horn from one guinea-pig was added 5jug of arachidonic
acid, dissolved in 0.02 ml ethanol, to give a concentration of 0.5^tfg/ml. To the
corresponding homogenised right or left uterine horns from each animal was added
0.02 ml ethanol.
Similarly 25jbLg arachidonic acid, in 0.1 ml ethanol, was added to the homogen¬
ised right uterine horns from two guinea-pigs and left uterine horn from one guinea-
pig to give a concentration of 2.5 ^g/ml. To the remaining three homogenised horns
was added 0.1 ml ethanol. All homogenates were then bubbled with 95% oxygen, 5%
carbon dioxide and incubated at 37°C for 90 minutes. Following this period, each
homogenate was adjusted to pHA with hydrochloric acid and solvent extracted immediately.
Silicic acid column chromatography of each extract subsequently followed.
5) Homoreni3ation of Guinea-pig Uterus and Incubation in Kreb's Solution
Containing Hvdroquinone and Reduced Glutathione
Three guinea-pigs on day 6 of the cycle were killed, their uterine horns removed,
separated and weighed. bach horn was homogenised in 5 ml Kreb's solution, hcmogen-
isation being completed within 5 minutes. The hcmogenate produced in each case was
poured into a 25 ml flask and the homogeniser rinsed with a further 5 ml Kreb's solu¬
tion. The washings were also added to the flasks. Hydroquinone (11.2 ^1 of a 500
fjug/ml aqueous solution) and reduced glutathione (114 f*-1 of a 5 mg/ml aqueous solution)
were added to the hcmogenates of the right uterine horn from two guinea-pigs and the
left horn from the third guinea-pig. Thi3 produced final concentrations of hydro¬
quinone and reduced glutathione of 0.56 y^g/ml and 57ydg/ml respectively.
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All hcmogenates were then bubbled with 95% oxygen, 5% carbon dioxide and
incubated at 37°G for 90 minutes. Each incubate was then adjusted to pH4 with
hydrochloric acid and solvent extracted. Each extract obtained was subjected to
silicic acid column chromatography.
6) Homopenlsation and Incubation of Guinea-pig Uterus in Kreb's Solution
Containing Phospholipase A
Three guinea-pigs were killed on day 6 of the cycle, their uterine horns removed,
separated and weighed. The right horn from two guinea-pigs and the left horn from
the third were homogenised separately, each in 5 ml Krebs' solution containing phos¬
pholipase A (5 ^U.g/ml). A small quantity of ether (0.25 ml) was also added to facili¬
tate the action of the enzyme. The hcmogenate of each horn was poured into a 25 ml
fla3k. The homogeniser was washed with two further 5 ml portions of Krebs1 solution
containing phospholipase A and the washings added to the flask.
The remaining left and right uterine horns from the guinea-pigs were similarly
homogenised, but in Krebs' solution which did not contain phospholipase A. The
same quantity (0.25 ml) of ether was added. The homogenates were made up to a
volume of 15 ml, again by washing the homogeniser with two 5 ml portions of Krebs1
solution.
Homogenisation in all cases was complete in five minutes and all hcmogenates
were incubated at 37°C for 15 minutes, whilst being bubbled with 95% oxygen, %
carbon dioxide. At the end of this period, four volumes of ethanol were added to
each incubate to stop any further enzymic action. Each incubate wa3 then evaporated
to dryness under reduced pressure and the residue obtained shaken with 10 ml of water.
The resultant suspension was adjusted to pHA with hydrochloric acid and solvent
extracted. The extracts from the uterine horns incubated in the presence of phos¬
pholipase A were combined, as were those frcm horns incubated in its absence. The
two resultant extracts were subjected to silicic acid column chromatography.
7) Homorenisation arri Incubation of Guinea-pig Uterus in Krebs' Solution
Containing Indomethacin
Three guinea-pigs on days 3, 6 and 13 of the cycle were killed, their uterine
horns removed, separated and weighed. The left horn from two guinea-pigs and the
right horn from the third were homogenised each in 5 ml Krebs1 solution containing
indomethacin (5 yug/ml). Previously 10 mg of indcmethacin had been dissolved in 10 ml
absolute ethanol to produce a concentration of 1 mg/ml. A volume of 0.075 mlcf this
solution was added to 15 ml Krebs' solution to produce the required concentration of
indomethacin of 5 yttg/ml.
Each homogenate was poured into a 25 ml flask, the hcmogeniser washed twice with
5 ml portions of Krebs' solution containing indcmethacin and the washings added to the
flask. Similarly, the remaining right and left uterine horns from the guinea-pigs
were homogenised separately in 5 ml Krebs1 solution to which indcmethacin had not been
added. However, the Krebs * solution did contain an equivalent amount of alcohol
(0.075 ml in 15 ml of solution). Each hcmogenate was again poured into a 25 ml flask
and the homogeniser similarly washed.
All hcmogenate3 were bubbled with 95% oxygen, 5% carbon dioxide and incubated at
37°C for 90 minutes. Following this period, each incubate was adjusted to pHl with
hydrochloric acid and solvent extracted immediately. The extracts from the uterine
horns incubated in the presence of indomethacin were combined, as were those from
horns incubated in its absence. Both resultant extracts were then subjected to
silicic acid column chromatography.
8) Introduction of Prostaglandin F^ into the Uterine Lumen of Guinea-pigs and
its Subsequent Detection in the Utero-ovarian Venous Blood.
i) Collection of Utero-ovarian Venous Blood Following, the Introduction of
Prostaglandin F„ac into the Uterine Lumen (performed by F. R. Blatchley
and B. T. DonovanJI
Four guinea-pigs on day 12 of the cycle were U3ed. Prostaglandin F^oc (100jjug)
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was dissolved in 0.2 ml normal saline and adjusted to pH 8 with sodium bicarbonate.
This solution was introduced into the lumen of one uterine horn, and blood collection
frcm the appropriate vein started within the next two minutes. Collection continued
for 1 to l| hours. The blood obtained was centifruged, the plasma separated and
frozen at -20°C until extracted.
ii) Extraction of Flasma
Each plasma sample was extracted by the procedure described in section 1,
experiment 2 (methods). The dry residue obtained was dissolved in 0.5 ml 30$
ethyl acetate in benzene and subjected to silicic acid column chromatography.
Extraction of Prostaglandins: In experiments 1 - ? prostaglandins were extracted
by a similar but shortened method to that described in section 1, experiment 2
(methods). The aqueous hcmogenate or incubate was adjusted to pH 4 with hydrochloric
acid and partitioned three times with two volumes of ethyl acetate. The ethyl acetate
fractions were combined, washed with a small quantity of water (0.1 volume) then evap¬
orated to dryness. The residue was dissolved in 20 ml 67$ ethanol, washed twice with
20 ml petroleum spirit (bp 60-30°C) then evaporated to dryness. The dry extract
obtained, alone or combined with similar extracts, was dissolved in 30$ ethyl acetate
in benzene or toluene and subjected to silicic acid column chromatography.
Silicic Acid Column Chromatography: This was performed as described in previous
sections. Columns of 4.2^silicic acid (Signa SIL-R, low grade, 100 meshj or Bio-
Rad Labs BIO 3IL A, 100-200 mesh, control no. 6583A) were used. They were eluted
by increasing concentrations of ethyl acetate in benzene or toluene, with a final
elution by methanol (see section 3, methods). Prostaglandins of the "E" series are
eluted by 65$ ethyl acetate in benzene or toluene (fraction 4), prostaglandins of
the "F" series by 80$ ethyl acetate in benzene or toluene (fraction 6). The frac¬
tions obtained frcm the column were evaporated to dryness, under reduced pressure,
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the residues dissolved in 1 ml water and assayed on the rat fundal strip, as described
in section 1 (methods) against a standard solution (100 ng/ml) of the appropriate
prostaglandin. Fractions 1 to 5 were assayed against prostaglandin in experi¬
ments 1, 2, 3 and 8 and against prostaglandin Eg in experiments 4 to 7. In all
experiments fractions 6 to 8 were assayed against prostaglandin Fg<* -
Identification of Prostaglandins by Combined Gas Chromatography and Mass Spectrometry
i) Prostaglandins of the "F" Series: In every instance, fraction 6 from the
silicic acid columns, following bioassay, was evaporated to dryness, in vacuo, the
residue dissolved in 0.2 methanol and transferred to a 0.5 ml stoppered tube. The
methyl ester/trimethylsilyl ether (Me/TMS) was formed by the method described in
section 1, experiment 5 (methods). Ihe Me/TMS derivative of authentic prostaglandin
Fgc* was prepared and its retention time on gas chromatography noted. A mas3 spectrum
was taken at thi3 time. The Me/TM3 derivative of the material present in fraction 6
was then subjected to ga3 chromatography, a mass spectrum being recorded of the
effluent from the column at the previously noted retention time for authentic pros¬
taglandin Eg,or.
ii) Prostaglandins of the "E" series;
a) Fractions 4 from the silicic acid columns, following chromatography of
the extracts obtained from incubated uteri taken from guinea-pigs on days 3, 6, 11,
12 and 13, were combined and evaporated to dryness under reduced pressure. The
residue was dissolved in 0.2 ml methanol and spotted onto a TLC plate (20 cm x 5 cm)
coated with 3ilica gel (E. Merck A.G) to a thickness of 0.25 mm (test plate). The
plate had been previously dried and activated by heating at 110°C for 60 minutes.
The flask vhich had contained the residue was washed twice with 0.05 ml methanol and
the washings also spotted on to the plate. A similar plate which was to act as a
"marker" was spotted with 10 of prostaglandin E^. Both plates were run simul-
taneously using the AI solvent system of Green and Sanmelsson (1964), which consists
of benzene, dioxan and glacial acetic acid in the ratio of 20 s 20 i 1. A 10 cm
run on both plates was allowed. The marker plate was then visualised by spraying
with 10$ phosphomolybdic acid in ethanol and heating at 110°0 for five minutes. The
R., value for prostaglandin £. was determined. A zone of silica gel, 1.5 cm vide,J? X
the mid-line of which had an value equivalent to that of prostaglandin was
scraped off the test plate. The silica gel was eluted by washing with 5 ml methanol.
The resultant suspension was centifruged and the supernatant liquid withdrawn. This
was repeated using a further 5 ml of methanol. The two methanol fractions were com¬
bined, reduced in volume to 0.2 ml, by reduced pressure evaporation, transferred to a
0.5 ml stoppered tube and evaporated to dryness, in vacuo. The methyl ester/methoadme/
trimethylsilyl ether (Me/MC/Tf©) of the residue was prepared as In method 1, section
3, (methods).
The Me/MC/Tl© derivative each of 1/Ug of prostaglandins and Eg were also
prepared. These were injected on to the gas chromatographlc column and the retention
times for both stereoisomers of each compound noted. A mass spectrum was recorded at
these times. The i*)e/V£>/TM5 derivative of the extracted material was then injected on
to the gas chromatographic columns and a mass spectrum taken of the effluent from the
column at the previously noted retention times for both stereoisomers of the lie/MG/TM3
derivative of authentic prostaglandins and Eg.
b) Fractions 4 from the silicic add columns, following chromatography of
the extracted material obtained from the incubated uteri taken from guineafpifs on
days 14 and 15 of the cycle, were combined and analysed for prostaglandins of the "Gw
series in the manner described in method 2, section 3 (methods). This involves con¬
version of the prostaglandin of the WEH series into the corresponding one of the "B"
series and subsequent purifying by thin-layer chromatography. The Me/THS of toe
material eluted from the plate was prepared as in section 1, experiment 5, (methods).
The Me/TFS of 1 jig each of prostaglandins and were prepared also. Ihese were
injected on to the gas chromatographic column and their retention times noted. A
mass spectnsn was taken at this time. The Me/TliS derivative of the extracted material
was then Injected on to the gas chromatographic column and a mass spectrum of the
effluent was taken at the previously noted retention times for the Me/T^S derivative
of authentic prostaglandins and Bg.
Results
In some experiments performed in this section, fractions 1-5 from the silicic
acid columns were assayed in terms of prostaglandin E^. At that time no suitable
standard of prostaglandin Eg was available. In previous sections, prostaglandin FgOi
has been shown to be produced by the uterus of both the sheep and guinea pig, prostag¬
landin F-jt* having never been detected. In view of these findings, any prostaglandin
of the "E" series produced in the experiments in this section was more likely to be
prostaglandin E^ than E^. The fact that prostaglandins and share the same
precursor supports this view. Consequently the amount of any prostaglandin E-like
material which was extracted and assayed in terms of prostaglandin has been subse¬
quently expressed in terms of an equivalent amount of prostaglandin Eg. Prostaglan¬
din Eg is approximately twice as potent as prostaglandin E^ on the rat fundal strip
(personal observation).
1) Resting Levels of Prostaglandins in the Guinea-pig Uterus durinp the Oestrous
Cycle
No prostaglandin-like material of either the "E" series (< 1.0 ng KiEg/lOO mg
tissue) nor "F" series (<2.0 ng FGF^oc/lQO mg tissue) could be detected in the
guinea-pig uterus before day 13 of the cycle (see Table 16). On day 13 the level
of prostaglandin Fgt* in the uterus rose to the detectable level of 2.8 ng/100 mg
tissue, but no prostaglandins of the "E" series (< 0.7 ng/100 mg tissue) were detec-
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table. On day 14 the level of prostaglandin Fg£< had risen to 20.0 ng/lOQ mg tissue,
and there was a detectable level (2.2 ng/lOO mg tissue) of prostaglandin Eg. On day
15, the levels had declined to 4.8 ng/lOCtag tissue and 0.8 ng/100 mg tissue of prostag¬
landins Fgcx. and Eg respectively. It should be noted that the level of prostaglandin























3 2.7 <25 <13 <0.9 < 0.5
6 2.5 <50 <25 < 2.0 <1.0
9 2.2 <50 <13 <2.3 < 0.6
11 2.0 <25 <12 <1.2 <0.6
12 1.5 <25 <12 <1.7 <0.8
13 1.8 50 <13 2.8 < 0.7
14 2.1 420 45 20.0 2.2
15 3.1 150 25 4.8 0.8
Table 16: Levels of Prostaglandins F^oc (FGFg« ) and Prostaglandin
(FGEg) in the Uterus of Guinea-pip^ during the Oestrous Cycle.
Gas chromatography and mass spectrometry confirmed the presence of prostaglandin
FgC* in the uterus on days 14 and 15 of the cycle. This was accomplished as in
previous sections by comparing the mass spectral records of the Me/TMS derivative
of both the extracted material and authentic prostaglandin Fgoc , taken at the same
gas chromatographic retention time. The presence of common peaks at m/e values of
307, 333, 353, 379, 404, 423, 494, 513, 569 and 584, in approximately the same ratios,
showed conclusively that the extracted prostaglandin F-like material was in fact
prostaglandin Fg<x. Identification of the E-like material wa3 not attempted owing
to the small amounts isolated.
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In the control experiment where 400 ng each of prostaglandin and were
added to a hanogenate in ethanol of. the right uterine horn taken frem a guinea-pig
on day 6 and the left uterine horn taken from a guinea-pig on day 9, 250 ng of
prostaglandin and 350 ng of prostaglandin F^oc were subsequently recovered. No
prostaglandins were recovered from the control homogenate in ethanol of the left
uterine horn from the day 6 guinea-pig and the right uterine horn from the day 9
guinea-pig to which no prostaglandin had been added. These results showed that
prostaglandins could be recovered in fairly high yields by the methods used.
2) Amounts of Prostaglandins Produced by the Homogenised Guinea-pig Uterus
on Incubation
On every day of the oestrous cycle studied, the amounts of prostaglandins
extractable from homogenates of guinea-pig uteri incubated in Tyrode's solution
were greater than the amounts which were extractsble from ethanolic homogenates.
Therefore prostaglandin biosynthesis must have occurred during the hcmogeni3ation
and incubation in Tyrode. More significant was the finding that the amounts of
prostaglandins formed by the guinea-pig uterus increased towards the end of the
oestrous cycle. On days 3 to 13, the amount of prostaglandin F^cn formed by three
uteri on each day ranged from 750 ng to 1.5yUg. The amount rose to 3.35yU.g on
day 14, which was followed by a further rise to 4.1 ft-g on day 15. The amounts of
prostaglandin produced on days 3 to 13 ranged from 150 ng to 230 ng. A rise
to 800 ng and 900 ng occurred on days 14 and 15 respectively, (see Table 17). It
was noticeable that 4 to 5 times more prostaglandin Fg©< than prostaglandin was
formed on any one day of the cycle.
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Day of Combined Weight Amount of Amount of
Oestrous of three Prostaglandin
Extracted {juiT
Prostaglandin E^
Extracted (>ag)Cycle Uteri (g)
3 1.7 0.75 0.15
6 2.5 1.40 0.23
9 2.4 1.15 0.20
11 1.9 0.80 0.18
12 1.8 1.50 0.17
13 1.8 1.40 0.15
14 2.3 3.35 0.80
15 3.1 4.10 0.90
Table 17: Amounts of Prostaglandin F^pc and Prostaglandin Br Extracted
Durlnr the Oestrous Cycle From Guinea-pig Uteri Homogenised
and Incubated in Tyrode'3 Solution
During the oestrous cycle, the combined weight of three guinea-pig uteri varied,
although the weight on day 15 was noticeably heavier than on days earlier in the
cycle. Figure 16 shows therefore, the amounts of prostaglandins F^oc and Eg pro¬
duced by 100 mg of uterine tissue on the days studied. (These levels are corrected
for the amounts of prostaglandins which are present in the guinea-pig uterus and
were not formed during the hcmogenisation and incubation processes, see Table 16).
There was an increase in the amount of prostaglandin Fg<x. produced towards the end
of the cycle. The levels ranged from 43.6 to 56.8 ng/100 mg tissue on days 3 to 11,
rose to 82.8 and 74.1 ng/100 mg tissue on days 12 and 13 respectively and then increased
further to levels of 123.2 andl28.4 ng/100 mg tissue on days 14 and 15. The amounts
of prostaglandin Eg formed remained at a lower level throughout the oestrous cycle.
The levels on days 3 to 13, ranged from 7.8 to 9.3 ng/lOC mg tissue. A rise then
occurred to levels of 14.9 and 13.4 ng/lOG mg tissue on days 14 and 15 respectively.
Gas chromatography and mass spectrometry confirmed the identity of the prostag-
140.
3 6 9 11 12 13 14 15
DAY OF OESTROUS CYCLE
fip. 16
\mounts of prostaglandin F0o<; (i-Gi-' ex.) and prostaglandin (a;Gd0) formed
on incubation by guinea-pip uteri taken on selected days of tiie oestrous cycle.
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Jan&inF^c*, produced by the guinea-pig uteru3 on every day of the cycle studied.
This was again accomplished by comparing the mass spectral records, taken at the
same retention times on gas chromatography of the Me/'TMS derivative of the extracted
prostaglandin F-like material and authentic prostaglandin F^iX.. The presence in the
recording of the extracted material of the ten characteristic peaks of authentic
prostaglandin FgcK (Me/TFS) in approximately the same ratios confirmed that the extrac¬
ted material was prostaglandin Fgc* .
Mass spectrcmetric identification of the prostaglandin E-like material extracted,
although attempted, proved unsuccessful. The material extracted on days 3, 6, 11,
12 and 13 was bulked and converted to the methyl ester/methoxime/trimethysilyl ether
(Me/MG/TM3). The Me/MO/TFS derivative of prostaglandin E^, on gas chromatography,
had retention times for its two stereoisomers of 13.5 and 16.3 minutes respectively.
The same derivative of prostaglandin Eg had retention times of 12.1 and 14.8 minutes.
Mass spectra taken at these times of the effluent from the gas chromatographic column
of the Me/M0/TM3 derivative of the extracted prostaglandin E-like material contained
many peaks due to the presence of large amounts of interfering substances, in all
four instances. Thus any "prostaglandin peaks" were masked by the other peaks. No
conclusions could be drawn.
Similarly, no conclusions could be drawn regarding the prostaglandin E-like
material extracted on days 14 and 15. This material was converted to the corres¬
ponding prostaglandin B, then subjected to thin-layer chromatography. (Authentic
prostaglandin Bg had an Rp value of 0.32). The material eluted frcm the appropriate
zone of the plate was then converted to the Me/TM3 derivative. On gas chromatography,
the Me/TIB derivative of both prostaglandins and had a retention time of 17.1
minutes. A mass spectrum taken at this time of the effluent from the colimm of the
he/IMS derivative of the material eluted from the plate contained too many interfering
peaks for any conclusions to be drawn.
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3) Results of Hcmopenlsing a Guinea-pig. Uterus in Ice Cold "Water Followed
By Immediate extraction
Prostaglandins of both the "E" series and "F" series could be extracted from
the horaogenate of a uterus taken from a guinea-pig on day 6 of the cycle and homo¬
genised in ice-cold water. The amounts of prostaglandins Fg c* and Eg extracted
were 75 ng and 30 ng respectively. Gas chromatography and mass spectrometry shewed
traced amounts (25 to 50 ng) of prostaglandin Fgcx to be present in the extract,
thus producing confirmation of the bioassay result.
4) Effect of Exogenous Arachidonic Acid on Prostaglandin Production by the
Guinea-pig Uterus
Arachidonic acid (0.5 /fag/ml) incubated with the homogenates of guinea-pig uteri
taken from day 6 guinea-pigs did not affect the amounts of prostaglandins FgO< and
Eg produced. At the higher level of arachidonic acid (2.5 /wg/ml), the amount of
prostaglandin Eg produced was increased by approximately 100% in all three experi¬
ments. The amount of prostaglandin FgO< produced, however, was 30% to 40% lower
in two of the three experiments (see Table 18). More experiments are needed to














Test Control Test Control
1 0.5 77.6 78.2 3.4 3.0
2 0.5 60.3 51.8 3.5 3.5
3 0.5 62.0 59.7 2.2 2.7
4 2.5 33.7 53.2 10.1 5.3
5 2.5 69.4 67.3 6.4 2.8
6 2.5 56.1 79.5 7.9 3.5
Table 18: Amounts of Prostaglandin Fg<x (PGF„ <x) and Prostaglandin Eg (FGE„)
Produced by Homogenised Guinea-pit^'Uterine Horns Incubated in the
Presence of Arachidonic Acid (Test) and in its Absence (ControfT"
(Figures Quoted are the Mean of the Bioassay Result Obtained by
"Bridging")
100...-
The prostaglandin F^cx produced in every instance had its identity confirmed
by gas chromatography and ma3s spectrometry. Identification of the prostaglandin
I,-like material was not attempted due to the small amounts available.
5) The Influence of i) Hydroquinone and Reduced Glutathione and
ii) Phospholinase A on the Production of Prostaglandins
by the Guinea-pig Uterus
i) The production of prostaglandins Fg<x and Eg on incubation of hcmogenates
of guinea-pig uterine horns taken from day 6 guinea-pigs was not affected by the
addition of hydroquinone (0.56 ^g/ml) and reduced glutathione (57 ^£g/ml) to the
incubation medium (see Table 19). Also, since the uterine horn which was to receive
the treatment was alternated among the three guinea-pigs between the left and right
sides and since there was very little difference in the amounts of prostaglandins
produced by paired horns, it is concluded that the left and right uterine horns from
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Table 19: Amounts of Prostaglandins F^oc (PGP„oc) and Prostaglandin (FC.E^ )
Produced by Homopenised Guifeea-piguterine Horns Incubated tn the
Presence cf Hydroquinone (0.56 ppjml and Reduced Glutathione
(57 p'/ml) (Treated) and in their Absence (Non^treated)
The prostaglandin F,,o< isolated was identified by gas chromatography and mass
spectrometry in every case. No attempt was made to identify the prostaglandin
E-llke material.
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ii) Fhospholipase A added to the hamogenisation and incubation media, to produce
a concentration of 5 yU-g/ml, did not influence the amounts of prostaglandins produced
by the guinea-pig uterus on day 6, (see Table 20). In these experiments a shorter
incubation time of 15 minutes was used. The prostaglandin F^c* produced was identi¬
fied by gas chromatography and mass spectrometry.






Treated 1.28 175 27.5
Non-treated 1.29 175 22.5
Table 20i Amounts of Prostaglandin F^qc (PGF^qc) and Prostaglandin (PGE.J
Produced by the Guinea-pig Uterus incubated in the Presences of
Phospholipase A (5 <><r7ml) (Treated) and in its Absence (Non-treated)
6) The effect of Indcmethacin on the Production of Prostaglandins by the Guinea-pig
Uterus
Indomethacin at a dose level of 5 ^g/ml had a pronounced inhibitory effect on
the production of prostaglandins by the guinea-pig uterus, in vitro (see Table 21).
The biosynthesis of prostaglandin F^oo was inhibited by 62%, whilst that of prostag¬
landin Eg was inhibited by 77%• Gas chromatography and mass spectrometry identified
the prostaglandin F^cX, produced.
/
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Treated 1.39 400 38
Non-treated 1,39 1050 140
Table 21: Amounts of Prostaglandins Produced by the Guinea-pip Uterus
Incubated in the Presence of Imdomethacin (5/C/g/ml) (Treated)
and In its Absence (Non-treated)
7) Recovery of Prostaglandin F^cx from the Utero-ovarian Venous Blood of
C-uinea-rirs following its Introduction Into the Uterine lumen
Prostaglandin was recovered from the utero-ovarian venous blood of all four
guinea-pigs vised in this experiment. The amounts ranged from 0.1 to 12.2yjg (see
Table 22). These figures are based on the bioa33ay result. The value for the con¬
centration of prostaglandin FgO< in the blood has been corrected for a recovery








FGF2<x in Blood ( yug/ml)
3385 15.5 12.2 1.73
3425 7.8 0.1 0.02
3426 8.0 6.7 1.84
3444 15.0 1.3 0.19
Table 22: Amount of Prostaglandin (PGF^oc) Recovered frqn the Utero-
ovarian Venous Blood of Guinea-pirs following■the Introduction
of 100 tLZ into the Uterine Lumen
Ms experiment showed that prostaglandin F^cx present in the uterine lumen can
pass through the uterine tissue and appear in the uterine venous blood. This indi-
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cated that prostaglandin F^oc present in, or produced by uterine tissue can reach
the uterine blood vessels. These observation are of further significance in rela¬
tion to the results in section 4 where large quantities of prostaglandin Fg<x were
found in fluid present in the lumen of the sheep uterus and where prostaglandin F-
like material was present in the uterine venous blood. It is highly probable that
the prostaglandin was able to pass from the lumen of the sheep uterus into the uter¬
ine venous blood, in view of the present finding.
Conclusion
There were several findings of significance in this section.
a) Prostaglandin Fg<x could be detected in the guinea-pig uterine tissue on
days 13, 14 and 15 only. The levels were 2.8, 20.0 and 4.8 ng/100 mg tissue res¬
pectively. Smaller amounts of prostaglandin E-like material, which was assumed to
be prostaglandin Eg, were detected on days U and 15 (2.2 and 0.8 ng/100 mg tisaue).
b) The homogenised guinea-pig uterus possessed the ability to biosynthesise
prostaglandins on all days of the cycle studied. On any one day 4 to 5 times more
prostaglandin FgC< than prostaglandin Eg was formed.
c) The amount of prostaglandin Fg<* produced by the homogenised guinea-pig
uterus on incubation increased towards the end of the oestrous cycle. The levels
on days 14 and 15 (123.2 and 128.4 ng/100 mg tissue) were higher than the levels on
days 12 and 13 (82.8 and 74.1 ng/100 mg tissue) which, in turn, were higher than the
levels on earlier days of the cycle (43.6 to 56.8 ng/mg tissue).
The amounts of prostaglandin Eg formed on days 3 to 13 were 7.8 to 9.3 ng/100 mg
tissue. These amounts increased to 14.9 and 13.6 ng/100 mg tissue on days 14 and 15
respectively.
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The uterus of the guinea-pig secretes a luteolytic hormone near the end of
the oestrous cycle. The presence of a luteolytic substance in the uterus and an
increased ability of the uterus to biosynthesise such a substance at this time
might be expected. Prostaglandin Fg<x , a potent luteolytic compound, has new
been shown to be present in and produced by the guinea-pig uterus in amounts
greater on days 14 and 15 of the cycle than on earlier days in the cycle. Further
evidence lias therefore been obtained in favour of prostaglandin Fg<>< being the uter¬
ine luteolytic hormone (luteolysin).
Various factors which may have affected the biosynthesis of prostaglandins by
the guinea-pig uterus were also studied in this section. A guinea-pig uterus homo¬
genised in ice-cold water was still capable of synthesising small amounts of pros¬
taglandins FgO< (75 ng) and Eg (30 ng). A similar finding was reported for the bio¬
synthesis of prostaglandins by the homogenised rat stomach (Pace-Asciak, Morawska,
Coceani and Wolfe, 1963). Sheep vesicular glands were found to produce the same
amounts of prostaglandins irrespective of being homogenised and incubated in Ringer
solution or distilled water (Eliasson, 1959). 'Ihey were also formed at lower tem¬
peratures but in smaller amounts. Consequently the biosynthesis of prostaglandins
can proceed to varying degrees in different aqueous conditions.
Prostaglandins FgO< and Eg are biosynthesised from arachidonic acid (see
Bergstrom, 1966). However the incorporation of arachidonic acid into the incubation
medium did not increase the amount of prostaglandin FgoC produced. In fact, a
partial inhibition may have occurred in two experiments. The amount of prostaglan¬
din Eg formed, however, was doubled in the three experiments where the concentration
of arachidonic acid was 2.5/U-g/ml. Pace-Asciak et al, (1968) homogenised and incu¬
bated rat stomachs in the presence of labelled arachidonic acid. They found that
the percentage conversion of labelled material into prostaglandins wa3 very low,
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being 0.4$ in the case of prostaglandin Fgoc and 0.8$ in the case of prostaglandin
Eg. More prostaglandin Eg than prostaglandin Fgt* was formed from the exogenous
precursor. They speculated that the low conversion of labelled arachidonic acid
may have been due to the rapid dilution of the exogenous precursor by endogenous
arachidonic acid. The results they subsequently obtained supported this view.
The level of free arachidonic acid in rat stomachs, which had been removed from
rats and frozen immediately, was 8 to 11JAg/g. The level of arachidonic acid
present though as phospholipid was 1283 to 1466 yU-g/g. Homogenisation of tissue
arachidonic acid. A corresponding increase in the levels of prostaglandins Eg and
FgO< also occurred. Consequently, the failure of arachidonic acid added to the
homogenates of guinea-pig uteri to increase prostaglandin Fg production,and prostag¬
landin Eg production at the dose level of 0,5yt/g/ml, was probably due to the dilution
of the exogenous precursor by endogenous arachidonic acid.
Pace-Asciak et al, (1968) attributed the increase in the level of free arachidonic
acid to the enzyme, phospholipase A, liberating bound arachidonic acid from phosphol¬
ipids . Eliasson (1959) showed a 100$ increase in the production of prostaglandins
by sheep vesicular glands when incubated for 15 minutes in the presence of phospholi¬
pase A. In the experiments performed in this section, however, no increase in pros¬
taglandin production was obtained by incubating guinea-pig uteri with phospholipase A.
The ratio of prostaglandin Fgo< to prostaglandin Eg production by tissues may be
governed by the presence of certain co-factors (Nugteren et al, 1967), namely hydro-
quinone and reduced glutathione. However the inclusion in the incubation medium of
these two compounds at concentrations of 0.56 and 57 /<g/®l did not affect either the
ratio of prostaglandin FgOt to prostaglandin Eg produced, or the amounts produced.
Pace-Asciak et al, (1968) included hydroquinone and reduced glutathione in their
for 5 minutes in ice-cold phosphate
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incubation medium at the above concentrations. They reported that 3 to 4 times
more prostaglandin Fgc< than Eg was formed, though no figures were quoted for the
amounts of prostaglandins produced by the incubation of homogenised rat stomachs
in the absence of hydroquinone and reduced glutathione.
A significant inhibition of prostaglandin synthesis was achieved, by homogen¬
ising and incubating guinea-pig uteri in the presence of indomethacin. Ibis anti¬
inflammatory drug has recently been shown to inhibit the production of prostaglan¬
dins Fgoc and Eg from arachidonic acid by antagonising the prostaglandin synthesis-
ing enzymes (Vane, 1971). The result here obtained is in agreement with the recent
findings. It also confirms that the prostaglandin E-like material produced by the
homogenised guinea-pig uterus and which has assumed to be prostaglandin Eg was prob¬
ably a prostaglandin.
The finding that prostaglandin Fg<x introduced into the lumen of the uterus
can be subsequently detected in the utero-ovarian venous blood makes it highly prob¬
able that endogenous prostaglandins produced by the guinea-pig uterus can reach the
venous drainage.
To summarise this section briefly, small amounts of prostaglandins were detec¬
table in the guinea-pig uterus at the end of the oestrous cycle. The homogenised
guinea-pig uterus had the ability to synthesise prostaglandins on every day of the
cycle studied, though greater amounts were produced nearer the end of the oestrous
cycle than at times earlier. Prostaglandin Fgoc was the main prostaglandin formed.
Results obtained by Eliasson (1959) and Pace-Asciak et al, (1968) suggest that the
prostaglandins Fgc< and Eg produced were biosynthesised from free, endogenous
arachidonic acid which had been liberated from stores bound to phospholipids by
phospholipase A. Indomethacin was shown capable of inhibiting this prostaglandin
synthesis by the homogenised guinea-pig uterus.
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DISCUS 3I0N
Prostaglandin F^oc ha3 now been shown to be released from the uterus into the
venous blood of the sheep and guinea-pig in greater amounts towards the end of the
oestrous cycle than at times earlier. It is present in small quantities in toe
guinea-pig uterine tissue on days 14 and 15, whereas on earlier days, levels in the
uterus are belcw threshold for detection. The guinea-pig uterus can also biosyn¬
thesise prostaglandin Fg* in greater amounts on days 14 and 15, than at times earlier
in the cycle. This increase in biosynthesis on day 14 immediately precedes toe
large increase in level of prostaglandin F^oc which occurs in the utero-ovarian venous
blood of guinea-pigs between days 14 and 15. Furthermore, the increase in output of
prostaglandin F^oC by the uterus of the sheep and guinea-pig occurs just before toe
decline in progesterone production by the ovaries. Since prostaglandin Fg<* lowers
progesterone levels when infused into the sheep ovarian artery, these observations
are consistent with the hypothesis that prostaglandin F^oc production is the mechanism
by which oestrous cycle length is normally determined.
In the guinea-pig, the insertion of a foreign body into the uterus or the systemic
administration of oestrogen cause early regression of toe corpora lutea due to the
premature release of a uterine luteolytic agent (see introduction). Both these
treatments have now been shown to cause toe release of prostaglandin F^ex, a potent
luteolytic substance, from the uterus. In sheep bearing an autotransplanted ovary,
cyclic activity ceases, (Goding et al, 1967a, b). Progesterone levels remain high
due to the persistence of a corpus luteum in the transplanted organ. The uteri of
such sheep have now been shown to be producing large amounts of prostaglandin FgC< ,
which is probably being prevented from reaching the transplanted ovary in luteolytic
concentrations owing to its efficient removal from the circulation by the lungs
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(Ferreira and Vane, 1967). Consequently, in the absence of an effective luteolysin
the corpus luteum persists. Removal from the circulation after it has been released
by the uterus and before it can reach the transplanted ovary in luteolytic concentra¬
tions is an essential requisite of any substance which is being considered as the
uterine luteolytic hormone. Consequently, this observation in the sheep, together
with the results and observations obtained from the other experiments performed in
both the sheep and guinea-pig support the view that the uterine luteolytic hormone
(luteolysin) is prostaglandin F^oc.
However, this view is not in full agreement with the results obtained by earlier
workers. Luteolytic extracts isolated from uteri by previous researchers have usu¬
ally been protein-like in nature, although discrepancies in their results exist.
Lukaszewaska and Hansel (1970) isolated a uterine factor which was non-dialysable
and appeared to be a high molecular weight protein. Mazer and Wright (1963) extrac¬
ted a non-dialysable luteolytic factor which was also therraolablle. Schomberg (1967)
found a luteolytic factor which was thermolabile, non-dialysable and appeared to be a
high molecular weight protein. However, Caldwell et al, (1969a,b) isolated a luteo¬
lytic factor which, although non-dialysable, was relatively heat stable and of molecu¬
lar weight below 1500. Some of the discrepancies in these results may be due to the
luteolytic activity residing in a low molecular weight compound which was bound to the
protein. Prostaglandins are bound to proteins by as much as 90$ (Jone3 R. L., personal
communication) and consequently the luteolytic activity present in these extracts may
have been due to prostaglandin F^oc. Some of the extracts did in fact contain small
amounts of carbohydrate and/or lipid material (see Lukaszewaska and Hansel, 1970). It
is of interest to note that no subsequent results regarding the purification and isola¬
tion of a luteolytic protein from any of these extracts has been reported.
Duncan et al, (1961) isolated a factor from the uterus, near the end of the
oestrous cycle which was dialysable, heat stable, and inhibited progesterone syn¬
thesis, in vitro. Howsver, prostaglandin actually stimulated progesterone
synthesis, in vitro. (Speroff and Ramwell, 1970), although its effect when present
in endometrial extracts has not been studied. The factor isolated by Duncan et al,
(1961) was not tested, in vivo. They also isolated a factor from the uterus earlier
in the cycle which did stimulate progesterone synthesis, in vitro. Again its effect
in vivo was not studied. Consequently, it is difficult to relate these studies to
the present ones.
All the luteolytic extracts obtained from the uterus by these previous workers
came from animals which were near the end of their oestrous cycle or pseudopregnancy.
Extracts obtained earlier, vhere prepared, were ineffective. Assuming that the luteo¬
lytic activity may have been due to the presence of prostaglandin , the observations
are in agreement with the present findings that prostaglandin F^oc is detectable in the
guinea-pig uterus On days 14 and 15 only. However the amounts present are 3mall in
comparison to the amounts which the uterus can biosynthesise on those days. This may
be of significance in explaining why these workers found luteolytic activity in uterine
extracts whereas others did not. Clo3e inspection of the techniques and methods
used in attempts to isolate a luteolytic factor from the uterus prove very interest¬
ing. Where luteolytic activity was found, the uterus had been homogenised in an
aqueous medium early in the isolation process. Hiis would have allowed the bio¬
synthesis of prostaglandin Fgoc to take place. Even the use of cold saline
(Lukaszewaska and Hansel, 1970) or water (Caldwell et al, 1969aj Duby et al, 1969)
would not have prevented its production (see section 5). The fact that luteolytic
activity was detected near the end of the oestrous cycle or pseudopregnancy may have
reflected an increase in ability of the uterus to biosynthesise prostaglandin F^oc at
110 -
those times. Amounts produced earlier may have been insufficient to cause corpora
luteal regression. Research workers who could not isolate a luteolytic factor frcm
the uterus seldom included an aqueous hcmogenisation stage in their extraction process.
Kiracofe et al, (1963, 1966), and Kiracofe and Spies (1966) prepared either ether
extracts or aqueous suspensions of lyophilised uteri, whilst Malven and Hansel (1965)
prepared ether and aqueous extracts of uteri which had been frozen for long periods.
It is unlikely that prostaglandin F^oc could have been formed during their isolation
processes. Consequently, the more careful and refined the technique, the less is
the likelihood of finding prostaglandin F^oc and luteolytic activityl The only way
to discover whether the luteolytic factor present in the "active" extracts was pros¬
taglandin F^<k is to prepare these extracts again and look for the presence of pros¬
taglandin Fg<X..
Some discrepancies also exist in the results of studies which involved the auto-
transplantation of the ovary or uterus. Coding et al, (1967a,b), have found corpora
luteal regression to be inhibited if the ovary or uterus is autotransplanted to the
neck in sheep. Oestrous cycle length is considerably prolonged. However, KLswender,
Dziuk, Grober and Kaltenbach (1970) found oestrous cycle length to be little affected
in sheep if the uterus is autotransplanted to the omentum. Similarly, Bland (1970)
found oestrous cycle length to be increased only by 7 to 8 days following auto-
transplantation of the uterus to the abdominal wall. The technique he used involved
severing the vascular supply, ligating and cutting the tubal and cervical ends of the
uterus and then suturing the uterus to the flank muscles of the abdominal wall. The
uterus was not actually re-located. Loeb (1927) removed the uterus entirely from the
guinea-pig and auto-transplanted it subcutaneously in the abdomen. Regression of the
corpora lutea did not occur and the guinea-pigs did not return to oestrus. The only
apparent difference was the proximity of the uterus to the ovary. Bland (1970)
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suggests that "Where the uterus is transplanted to the abdominal vail, most of the
uterine venous drainage containing the uterine luteolysin is passing into the inter¬
nal iliac vein and it is conceivable that, from there, at least some of this venous
blood may reach the posterior vena cava via the uterine veins thus passing in close
proximity to the ovary." Where the uterus or ovary is autotransplanted to the neck
of placed just below the skin, a situation like this cannot arise. Therefore the
location of the autotransplanted organ may be very important in deciding, the effect
produced. However this does not explain why autotransplantation of the uterus to
the cheekpouch in hamsters can largely reverse the lengthened pseudopregnaney which
follows hysterectomy (Caldwell et al, 1967). This anomaly exists whether or not
prostaglandin is the uterine luteolytlc hormone.
However, there is no doubt that the vasculature of the ovary and uterus is a
very critical factor in luteolysis. All the evidence indicates that the uterine
vein is of prime importance (see introduction). The luteolytic hormone appears to
be secreted from the uterus into the venous blood, after which it exerts its effect
in a very local manner. A direct portal system between the uterus and the ovary has
not been reported. If prostaglandin is the uterine hormone, it must be capable
of inducing luteolysis after leaving the uterus in such a way that a uterine horn
effects only the ovary adjacent to it. One theory proposed by Pharriss, Cornette and
Gutknecht (1970) is based on the venoconstrictor activity possessed by prostaglandin
Fgcx (DuCharme, Weeks and Montgomery, 1968). The vein at the tubal end of the
uterus and the vein from the ovary unite to form a common "utero-ovarian" vein. They
propose that the luteolytic effect of prostaglandin F^cx is due to it producing a con¬
striction of this vein. Blood is prevented from passing through the ovary and this
reduction in blood flow is thought to induce luteolysis by seme means. Prostaglandin
Fgoc released by the uterus could affect the ovary in this way. However, McCracken
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et al, (1970) induced luteolysis in sheep without any reduction in blood flow through
the ovaries. Pharriss et al, (1970) admit themselves that their proposed mechanism
"seems quite casual for something as regular as the female sex cycle." It also
seems strange that the "stagnation" of blood in the ovary should affect only the
corpora lutea. Therefore this mechanism, although feasible^seems too improbable.
The ovarian artery in sheep is very convoluted where it runs in parallel with
the utero-ovarian vein and lies in very close proximity to it. Barrett, Blockey,
Brown, Gumming, Goding, Mole and Gbst (1971) found that surgical separation of the
ovarian artery from the surface of the utero-ovarian vein prevented luteal regres¬
sion in sheep. They proposed that substances might pass from the utero-ovarian
vein into the ovarian artery by means of a counter-current mechanism. McCracken
(1971) infused labelled prostaglandin Fg«* into the uterine vein of sheep and found
that the amount of radioactivity in the ovarian artery was thirty time/ greater
than that in the internal iliac artery. He concluded that in the case of pros¬
taglandin a counter-current mechanism can operate between the utero-ovarian
vein and the ovarian artery. Consequently, a mechanism appears to exist by which
prostaglandin F^x released from the uterus can reach the ovary and cause luteoly¬
sis. The finding that prostaglandin Fg<x infused into the uterus of pseudo-
pregnant rats induced luteolysis (Pharriss and Wyngarden, 1969) supports this view.
However, the efficiency of the transfer process may be critical. In section 2, the
main metabolite of prostaglandin F^cx could not be detected in the utero-ovarian
venous blood of guinea-pigs where prostaglandin F^cx was present. If the prostag¬
landin Fgoc released from a uterine horn is reaching the adjacent ovary by this
process and the ovary is not metabolising or binding it, after exerting, its effect
the prostaglandin F^« will leave the ovary and combine with more coming, from the
uterus. If the transfer process is 100% efficient, prostaglandin F^cx will be
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passing through the ovary, ad infinitum. Therefore a fairly low efficiency of trans¬
fer is necessary. Excess prostaglandin FgO*. which i3 not transferred will be removed
by the lungs and. will be prevented from reaching the ovary on the opposite side. How¬
ever, if the ovary can in fact metabolise prostaglandin Fgtx., obviously a high effic¬
iency of transfer is desirable. This speculation presupposes that prostaglandin F^oC
is in fact the uterine luteolytic hormone, but whether or not it is, some mechanism
must exist by which a luteolytic agent secreted by the uterus can exert its effect
in a very localised manner.
The actual means by which prostaglandin F^ck can cause luteolysis is unknown.
The fact that luteolysis results when prostaglandin F^c*. is infused directly through
the ovary (McCracken et al, 1S70) infers that it is acting in the ovary. However,
Labhsetwar (1970) has shown that the LH stores in the pituitary of rats treated with
prostaglandin F^oc are higher than in control animals. He suggests that the luteo¬
lytic effect of prostaglandin F^ix. may be mediated in part by the increased synthesis
and secretion of LH. However, Duncan and Fharriss (1970) have shown that prostag¬
landin Fg(x causes regression of corpora lutea in hypophysectomised rats receiving
LtH treatment. In control hypophysectanised rats LtH maintained luteal function.
Therefore, the pituitary cannot be involved. This is in keeping with prostaglandin
Fbeing the uterine luteolytic hormone, since the luteolytic effect of the uterus
on the ovary cannot be mediated by the pituitary (3ee introduction).
In the ovary, therefore, prostaglandin F^oc may act directly on the bio3ynthetic
pathways involved in steroidogenesis causing, the observed fall, in progesterone and
rise in 2CW-dihydroprogesterone levels (Fharriss and Wyngarden 1969} McCracken et
al, 1970). However, in vitro, prostaglandin Fgoc actually stimulates the production
of progesterone by bovine corpora luteal slices, (Speroff arri Fiamwell, 1970).
This difference in effect may be the result of the difference in experimental
conditions. Alternatively, prostaglandin FgCX. may cause the morphological regres¬
sion of corpora lutea, thus terminating the oestrous cycle or pseudopregnancy in
this way. This hypothesis could be tested. In a guinea-pig hypophysectomised
before day 5, the corpora lutea remain as morphological entities though appear to
be non-functional (Perry and Rowlands, 1962). The infusion of prostaglandin FgC<
through the ovaries of such guinea-pigs may indicate whether or not prostaglandin
FgC* can cause the morphological regression of corpora lutea, and induce luteolysis
by this means.
Hypophysectomy perfarmed in the guinea-pig on day 10 does not prevent regression
of the corpora lutea (Perry and Rowlands, 1962). Similarly, hypophysectcmy performed
in the hysterectomised guinea-pig is without effect on luteal function and the corpora
lutea are maintained (Rowlands, 1962). However, hypophysectcmy performed in the
hysterectomised sheep and pig results in spontaneous corpora luteal regression due
to the sudden withdrawal of a pituitary luteotrophin (see Anderson et al, 1969).
It is apparent that the secretions from the pituitary, ovary and uterus are dependent
upon one another and consequently investigations into the physiological stimulus nec¬
essary for the release of the uterine luteolytic hormone may prove difficult. How¬
ever, if prostaglandin F^ot is in fact the uterine luteolytic hormone, oestrogen
must be a very strong candidate as forming at least part of this physiological stimu¬
lus since section 2 has shown oestrogen to release prostaglandin FgO* from the uterus.
Progesterone administration at the beginning of the cycle results in early regression
of the corpora lutea due to the premature release of the uterine luteolytic hormone
(see introduction). Thus this steroid may form part of the physiological stimulus
also. However the possibility that they may be acting via the posterior pituitary
cannot be ruled out. Consequently, the anterior pituitary hormones LH, FSH and/or
LtH may be the essential stimuli.
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Oxytocin, a hormone from the posterior pituitary may be involved also since it
is luteolytic in the cow, its effect being mediated via the uterus (Armstrong and
Hansel, 1959)• In cows also, ACTH from the anterior pituitary, causes the early
regression of the corpus luteum and is without effect in the hysterectomised animal
(Brunner et al, 1970). This implies that it is causing, the premature release of
the uterine luteolytic hormone. However, the fact that 9-fluor©prednisolone causes
luteal regression in sheep (Denamur, 1968, as reported by Anderson et al, 1969) indi¬
cates that ACTH is probably acting initially on the adrenal glands causing the release
of adrenocorticosteroids, which in turn act on the uterus. The whole picture is,
therefore, 3amewhat complex, with hormones from the ovaries, the adrenal glands, the
posterior and anterior pituitaries possibly all being involved.
However, it is clear that the luteolytic effect of the uterus overrides the
luteotrophic effect of the pituitary since the latter effect is seen to persist in
the hysterectomised animal for a considerable length of time (see introduction). In
the early stages of pregnancy though, the luteolytic effect of the uterus has to be
negated, since ovarian progesterone is essential for the pregnancy to proceed normally
at this time. In the guinea-pig, the placenta appears to produce a sy3temically-borne
agent capable of neutralizing the luteolytic abilities of the uterus (Bland and
Donovan, 1969b). This agent seems to be mare anti-luteolytic than luteotrophic.
In the sheep, the presence of embryos in the uterus after day 12 prolongs corpus
luteum function (Moor and Rowson, 1966b). Furthermore, the intra-uterins infusion
of hcmogenates of day 14 or 15 sheep embryos increases oestrous cycle lengths (Rowson
and Moor, 1967). Thus the sheep embryo also appears to produce an anti-luteolytic
agent.
In the hamster, pseudopregnancy lasts 9 days. Ihis is doubled to 18 days in
the hysterectomised animal (Caldwell et al, 1967). Extracts of sheep uteri which
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were found capable of inducing luteolysis in the pseudopregnant hysterectomised
hamster, were incapable of terminating pregnancies when injected into pregnant
hamsters on days 5 to 8 (Caldwell et al, 1969a). Assuming that the hamster placenta
also produces an agent which is capable of neutralising the luteolytic effect of the
uterus, these observations indicate that the agent probably antagonises the effect
of the uterine luteolytic hormone on the ovary rather than to inhibit its synthesis.
Consequently, if sheep embryo homogenates were found capable of antagonising luteo¬
lysis induced by injected prostaglandin Fgoc, further evidence for this prostaglandin
being the uterine hormone would be obtained.
There has been one other report of prostaglandin F^oc occurring in the uterine
venous blood of sheep. There is an increased activity of the sheep foetal adrenal
gland which begins five days before parturition, (Liggins, 1969). Liggins and
Grieves (1971) have shown labour to be induced following the infusion of dexamethasone
into pregnant sheep of 126 to 140 days gestation and that the level of prostaglandin
Fgoc in the uterine venou3 blood of these sheep is between 2.4 and 37.0 ng/ml. Also
the amount of prostaglandin F^ot present in the myometrium rises from a pre-infusion
level of 97 ng/g to a level of 383 ng/g 24 hours after the initiation of the infusion.
In humans, labour may be due to prostaglandin F^oc (Karim, 1968) and the infusion of
prostaglandin F^oc near term results in parturition (Karim, Trussel, Patel and Hillier,
1968). Therefore a rise in level of prostaglandin FgO<. in the uterine venous blood
of sheep could be a major factor in the mechanism by which foetal adrenal activity may
initiate parturition.
However, increased adrenal activity of the foetus may not be solely involved.
Challis (1971) has 3hown a tenfold increase to occur in the level of plasma total
oestrogen on the day before parturition in the sheep. This oestrogen probably
originates from the placenta. Consequently, the adrenal gland of the foetus may be
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involved in the secretion of increased amounts of steroid precursors necessary for
placental oestrogen biosynthesis by the placental aromatizing enzyme systems (Ains-
worth and Ityan, 1966). Consequently as prostaglandin Fg<x has been implicated in
causing labour, this increase in the level of plasma oestrogen just before partu¬
rition may be of significance in view of the findings that oestrogen administration
in the guinea-pig does cause prostaglandin F^c* release from the uterus (see section
2). A study into the level of prostaglandin F^oc in the uterine venous blood of
sheep during the latter stages of pregnancy should be studied.
The observation that following an infusion of dexamethasone into pregnant sheep
prostaglandin F^c* is present in the uterine venous blood is very interesting in
another context. Since 9-fluoroprednisolons and ACTH possess luteolytic activity,
which for ACTH was shown to be absent in the hysterectomised animal, an obvious infer¬
ence is that they cause the release of prostaglandin Fg<x from the uteru3 which in
turn causes the regression of the corpora lutea. If this were found to be the case,
further evidence would be provided in support of the hypothesis that the uterine
luteolytic hormone (luteolysin) is prostaglandin F^cx.
McCracken (1971) has stated: "In order to obtain conclusive proof that PGF^ot
is the luteolytic factor from the uterus of the sheep, it will be necessary to demon¬
strate levels of FGFgoc in uterine venous blood which can cause luteolysis of the
adjacent corpus luteum via a counter-current mechanism," The results obtained in
section 3 have shown the prostaglandin levels in the uterine venous blood of
sheep to satisfy this criterion, as do the levels in the guinea-pig. The release
of prostaglandin F^cx* from the guinea-pig uterus in response to distension and
oestrogen treatment, its presence in and production by the guinea-pig uterus in
greater amounts towards the end of the oestrous cycle and its presence in the
uterine fluid of sheep with an autotransplanted ovary provide additional support
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to these observations. Consequently, on the basis of McCracken's criterion and
in view of all the findings in this investigation it can be concluded that the
uterine luteolytic hormone (luteolysin) is prostaglandin F^.
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Identification of prostaglandin F2a released by distension of guinea-pig
uterus in vitro. By N. L. Poyser, E. W. Horton, C. J. Thompson and M. Los.
Department of Pharmacology, University of Edinburgh, 1 George Square, Edin¬
burgh, EH 8 9JZ, Scotland
Thirty-five guinea-pigs were killed on day 3 of the oestrous cycle and the uterine
horns removed and separated. One horn from each animal was distended by the inser¬
tion of a piece of polyethylene tubing, 3 mm wide and 30 mm long, into the uterine
lumen. The other horn was left untouched and acted as the control. Each horn was
incubated separately in 10 ml of Tyrode's solution and gassed with oxygen at 37 °C for
5 h. Following this period, the incubation fluid surrounding the distended horns was
pooled so as to give one test sample. Likewise, the fluid surrounding the non-distended
horns was pooled so as to give one control sample. Both sampleswere purified by solvent
extraction and silicic acid column chromatography for the isolation and separation of
the different prostaglandins. Biologicalactivityof the fractionswas estimatedon the rat
fundal strip. The amount of prostaglandin E-like material in both test and control
samples was small and about equal. However, there was a tenfold difference in the
amount ofprostaglandin F-like material. The test sample contained the equivalent of
1 jag F2a, the control sample the equivalent of 0-1 fig E2a. A second expt on 30 animals
confirmed this result. Gas chromatography and mass spectrometry provided conclusive
evidence for the identification of prostaglandin F2a in the test sample. The amounts
agreed with the biological assay result. No prostaglandin F2a could be detected in the
control sample since the amount present was subthreshold for detection. In addition,
on gas chromatographic evidence, no prostaglandin h\a nor the main guinea-pig urin¬
ary metabolite of prostaglandin F2a (5,7-dihydroxy-ll-oxo-tetranor-prostanoic acid)
could be detected in either test or control sample. It is concluded that distension of
the guinea-pig uterus in vitro releases prostaglandin F2a.
Donovan & Traczyk (1962) showed that distension of the guinea-pig uterus in vivo
caused premature regression of the corpora lutea. This has been attributed to the
premature release of the uterine luteolytic substance, ltuteolysin, whose chemical
identity is still unknown. Blatchley & Donovan (1969) have shown that prostaglandin
F2a is luteolytic when injected into hysterectomized guinea-pigs. The result of this
investigation may link these two observations. It provides evidence in support of the
hypothesis that luteolysin is identical with prostaglandin F2a.
This work was supported by a grant from the Wellcome Trust. Prostaglandin F2a
was kindly supplied by the Upjohn Company.
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LEVELS OF PROSTAGLANDIN F2a IN THE UTERINE VENOUS BLOOD OF SHEEP
DURING THE OESTROUS CYCLE
K.P. Bland1, E.W. Horton and N.L. Poyser2
(Received in final form 29 March 1971)
Overwhelming evidence has accumulated over the last decade for
the existence in many mammalian species of a luteolytic hormone
(luteolysin), secreted by the uterus (1). However, attempts to
isolate and identify this hormone have met with little success
until quite recently. Distension of the uterus on days 2 to 4
of the oestrous cycle or oestrogen administration midcycle in
guinea-pigs has been shown to cause the early regression of the
corpora lutea due to the premature release of a uterine luteo¬
lytic substance (2, 3). Under both these conditions
prostaglandin F2a is released from the uterus (4, 5, 6). Since
prostaglandin F2a has a luteolytic action in the rat (7),
rabbit (8), guinea-pig (9), sheep (10) and monkey (11), its
release may well account for the luteolytic action of the uterus.
We now report an investigation of the concentrations of
prostaglandin F2a in uterine venous blood estimated in sheep
during the oestrous cycle.
1
Department of Veterinary Physiology, Royal (Dick) School of
Veterinary Studies, Summerhall, Edinburgh. EH9 1QH
2 Department of Pharmacology, University of Edinburgh, 1 George
Square, Edinburgh. EH8 9JZ
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Methods
Mature Cheviot ewes were checked for oestrcus by pairing
with a vasectomised ram once or twice daily. The first day of
acceptance was taken as day 1 of the cycle.
Laparotomies were performed on selected days of the cycle
and 40 ml samples of uterine venous blood withdrawn. A 25 ml
sample and an 80 ml sample were taken, however, from ewes on
day 2 and on day 15 respectively. Anaesthesia was induced and
maintained with halothane and nitrous oxide. No ewe was operated
on more than twice, and each animal was killed several days after
the final operation. An autopsy was performed to ensure that the
uterus and ovaries were of normal appearance.
Each sample of blood obtained was centrifuged and the red
cells discarded. The plasma was extracted by the method of
Bergstrom and Samuelsson (12), omitting the initial ethanol
stage. The dry residue remaining was dissolved in 0.5 ml 30%
ethyl acetate in toluene and subjected to silicic acid column
chromatography (13). Columns of 4.2 g silicic acid (Sigma SIL-R,
100 mesh; or Bio-Rad Labs. BIO SIL A, 100-200 mesh, control no.
6910 or 6583 A) were used. The columns were eluted in a stepwise
manner with increasing concentrations of ethyl acetate in toluene.
However, when columns were prepared using Bio-Rad Labs, silicic
acid, control no. 6910, a small percentage (1 - 5.5%) of
methanol was added to each fraction to aid elution. Prosta¬
glandins of the 'F' series are eluted by 80% ethyl acetate in
toluene. However, if these columns (4.2 g) are overloaded with
material (e.g. if the blood sample was slightly haemolysed) the
prostaglandin tends to be eluted by an earlier fraction of 65%
ethyl acetate in toluene. This can be overcome by using larger
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columns (10 g). The fractions obtained from the columns were
evaporated to dryness on a rotary evaporator at 45°C. The
residues remaining were dissolved in 1 ml of water, and assayed
on the rat fundal strip against a standard solution of prosta¬
glandin F2a (100 ng/ml).
A peripheral sample of blood (40 - 45 ml) was taken from the
jugular vein during most operations. To this was added
sufficient prostaglandin F2a to produce a final concentration of
10 ng/ml. To one jugular venous sample from a sheep on day 15
prostaglandin was not added. These samples were treated in
exactly the same manner as just described. They provided
estimates as to the percentage recovery of prostaglandin F2a from
blood, and to the reliability of the extraction and isolation
processes as a whole.
Identification of prostaglandin F2a The fractions from the
silicic acid columns in which prostaglandin F2a appeared or would
have appeared if present, were subjected to analysis by combined
gas chromatography and mass spectrometry. This process has been
developed recently for the detection and identification of
prostaglandins in submicrogram quantities (14). Following
bioassay, the methyl ester/trimethyl-silyl ether (Me/TMS) of the
appropriate fractions was prepared. The fraction was evaporated
to dryness, in vacuo, and the methyl ester formed by a reaction
for 30 minutes with a freshly prepared solution of diazomethane
in diethyl ether-methanol (9:1). Following this period, the
excess solution was vaporised, and the trimethylsilyl ether
formed by the addition of 15 pi of bis-(trimethylsilyl)-
trifluoroacetamide (BSTFA).
The Me/TMS derivative of authentic prostaglandin F2a
(250 ng and 125 ng) was prepared in a similar manner except that
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25 |il of BSTFA was added in the final stage. Ten microlitres
were injected on to the gas chromatographic column, the retention
time for authentic prostaglandin F2a being noted. A mass
spectrum was taken at this time.
Ten microlitres of the Me/TMS derivative of the appropriate
fraction from the silicic acid columns were injected also on to
the gas chromatographic column. A mass spectrum of the effluent
from the column was taken at the previously noted retention time
for the Me/TMS derivative of authentic prostaglandin F2a.
Results
The oestrous cycle in all nine ewes was 17 days in length.
The operational procedure had no effect on the recurrence of
oestrus although in two ewes behavioural oestrus was either weak
or absent. This was probably due to the close proximity of the
end of the breeding season. At autopsy, the uterine horns and
ovaries appeared normal. Consequently, there was no reason to
suspect that the collecting of uterine and peripheral venous
blood samples had affected the sheep in any way. The recovery
experiments with peripheral blood showed that the average
recovery was 46.7% (range 42.5% - 53.3%), and the activity was
confirmed by gas chromatography and mass spectrometry as due to
prostaglandin F2a in every case. No prostaglandin F2a
(<2.9 ng/ml) could be detected in the peripheral venous blood,
taken from sheep on day 15, to which prostaglandin F2a had not
been added.
The estimated levels of prostaglandin F2a in the uterine
venous blood taken from ewes during the oestrous cycle and
corrected for a 46.7% recovery are shown in the last column of
Table 1. These figures are based on the combined evidence of
bio-assay, gas chromatography and mass spectrometry.
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2 2 < 35 Possible trace <3.0
8 4 <50 n.d. <2.7
2 7 <50 n .d. <1.9
10 7 50-75 n.d. <2.7
10 9 <50 n.d. <2.7
3 10 180-200 Possible trace <2.7
12 11 < 50 n.d. <2.7
5 13 < 50 n .d. <2 .7
3 14 135-165 PGF2a present 7.2-8 .8
6 15 115-135 - 6.1-7.2
11 15 120-130 PGF2a present 3.2-3.5
4 16(a) 90-120 PGF2a present 4.8-6.4
4 16(b) 60-80 - 3.2-4.3
n .d. means no PGF2a detected.
- means PGF2a peaks masked by interfering substances.
(a) and (b) are from different cycles.
From day 2 to day 13 no prostaglandin F20! could be identified
in uterine venous blood, whereas on days 14, 15 and 16 the
estimated levels ranged from 3.4 to 8.0 ng/ml.
In ewe 10 (day 7) and ewe 3 (day 10) there was a smooth
muscle stimulating activity in the fractions from the silicic
acid column but this was not due to prostaglandin F2a as shown
conclusively by the results of gas chromatography and mass
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spectrometry.
In ewe 6 (day 15) and ewe 4 (day 16b) the final extract
contained unusually large amounts of interfering substance thus
conclusive mass spectral confirmation could not be obtained.
Examples of the evidence provided by mass spectrometry are
shown in Fig. 1. Peaks of ^ above 400 are of most significance,
since peaks below this tend to be lost in the background noise.
The Me/TMS derivative of authentic prostaglandin F2a has ^ peaks
at 404, 423, 494, 513, 569 and 584. These were present, in the
correct ratios, in the trace obtained from ewe 3 (day 14), but
were not present in the trace from ewe 2 (day 7).
FIG. 1
Line diagrams of mass spectra peaks greater than 400) of the
Me/TMS derivative of extracted and chromatographed uterine venous
blood samples taken from sheep on day 14 and day 7, and of
authentic prostaglandin F2a.
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The uterine venous extracts from both sheep gave five other peaks
which were not found in authentic prostaglandin F2a. These are
due to a common impurity. This evidence shows that prostaglandin
F2a is present in the uterine venous blood taken on day 14, but
not in the uterine venous blood taken on day 7. Similar
conclusions were drawn regarding other samples.
Conclusion
The results of this investigation show that prostaglandin
F2a is present in the uterine venous blood of sheep towards the
end of the oestrous cycle (days 14, 15 and 16). The levels range
from 3.3 to 8.0 ng/ml. No prostaglandin F2a was detected in the
uterine venous blood of sheep at any stage earlier in the cycle.
Furthermore, prostaglandin F2a was not present in the venous
blood taken from the jugular vein of ewe 11 on day 15, whereas
the uterine venous blood contained 3.3 ng/ml.
In sheep with normal oestrous cycles, the progesterone level
of the corpus luteum falls sharply on day 15 with complete
regression on day 16 (15). Since the local vascular system,in
some way, provides the pathway for the luteolytic action of the
uterus on the ovary, the presence of a luteolytic substance in
the uterine venous blood shortly before day 15 would be expected.
Our observation that prostaglandin F2a is present in the uterine
venous blood of sheep on days 14 to 16 of the cycle, and at no
other time, supports this hypothesis.
The luteolytic action of prostaglandin F2a appears to be
quick in onset, for the level of progesterone in the ovarian vein
falls within one hour after the initiation of a continuous
infusion (50 pg/hr) of prostaglandin F2a through the ovarian
i 0
artery OSO . A fall in progesterone levels occurs also with
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infusion rates of 0.01 and 1.0 gg/hr, levels in keeping with the
present findings. Consequently, the evidence presented here
supports the hypothesis that the uterine luteolytic hormone is
prostaglandin F2a.
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